Keywords
Last Name
Institution

JOSEPH JANKOVIC

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Neurology
DivisionNeurology
Address7200 Cambridge Street, M.S. BCM609
9th Floor, Suite 9A
Houston TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Jankovic J. Statin-related musculoskeletal pain in Parkinson's disease. Pain. 2017 Sep; 158(9):1840. PMID: 28816887.
      View in: PubMed
    2. Rousseaux MWC, Shulman JM, Jankovic J. Progress toward an integrated understanding of Parkinson's disease. F1000Res. 2017; 6:1121. PMID: 28751973.
      View in: PubMed
    3. Frank S, Stamler D, Kayson E, Claassen DO, Colcher A, Davis C, Duker A, Eberly S, Elmer L, Furr-Stimming E, Gudesblatt M, Hunter C, Jankovic J, Kostyk SK, Kumar R, Loy C, Mallonee W, Oakes D, Scott BL, Sung V, Goldstein J, Vaughan C, Testa CM. Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea. JAMA Neurol. 2017 Jul 10. PMID: 28692723.
      View in: PubMed
    4. Tarakad A, Jankovic J. Anosmia and Ageusia in Parkinson's Disease. Int Rev Neurobiol. 2017; 133:541-556. PMID: 28802932.
      View in: PubMed
    5. Baizabal-Carvallo JF, Jankovic J. Functional (psychogenic) stereotypies. J Neurol. 2017 Jun 26. PMID: 28653211.
      View in: PubMed
    6. Jankovic J. Botulinum toxin: State of the art. Mov Disord. 2017 Jun 22. PMID: 28639368.
      View in: PubMed
    7. Tarakad A, Jankovic J. Diagnosis and Management of Parkinson's Disease. Semin Neurol. 2017 Apr; 37(2):118-126. PMID: 28511252.
      View in: PubMed
    8. Carecchio M, Mencacci NE, Iodice A, Pons R, Panteghini C, Zorzi G, Zibordi F, Bonakis A, Dinopoulos A, Jankovic J, Stefanis L, Bhatia KP, Monti V, R'Bibo L, Veneziano L, Garavaglia B, Fusco C, Wood N, Stamelou M, Nardocci N. ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients. Parkinsonism Relat Disord. 2017 May 10. PMID: 28511835.
      View in: PubMed
    9. Pirio Richardson S, Altenmüller E, Alter K, Alterman RL, Chen R, Frucht S, Furuya S, Jankovic J, Jinnah HA, Kimberley TJ, Lungu C, Perlmutter JS, Prudente CN, Hallett M. Research Priorities in Limb and Task-Specific Dystonias. Front Neurol. 2017; 8:170. PMID: 28515706.
      View in: PubMed
    10. Berman BD, Junker J, Shelton E, Sillau SH, Jinnah HA, Perlmutter JS, Espay AJ, Jankovic J, Vidailhet M, Bonnet C, Ondo W, Malaty IA, Rodríguez R, McDonald WM, Marsh L, Zurowski M, Bäumer T, Brüggemann N. Psychiatric associations of adult-onset focal dystonia phenotypes. J Neurol Neurosurg Psychiatry. 2017 Apr 24. PMID: 28438790.
      View in: PubMed
    11. Robledo I, Jankovic J. Media hype: Patient and scientific perspectives on misleading medical news. Mov Disord. 2017 Apr 03. PMID: 28370445.
      View in: PubMed
    12. Wharen RE, Okun MS, Guthrie BL, Uitti RJ, Larson P, Foote K, Walker H, Marshall FJ, Schwalb J, Ford B, Jankovic J, Simpson R, Dashtipour K, Phibbs F, Neimat JS, Stewart RM, Peichel D, Pahwa R, Ostrem JL. Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trial. Parkinsonism Relat Disord. 2017 Mar 30. PMID: 28400200.
      View in: PubMed
    13. Kanaan RA, Duncan R, Goldstein LH, Jankovic J, Cavanna AE. Are psychogenic non-epileptic seizures just another symptom of conversion disorder? J Neurol Neurosurg Psychiatry. 2017 Feb 24. PMID: 28235779.
      View in: PubMed
    14. Jankovic J, Squitieri F. Letter re: Huntington disease reduced penetrance alleles occur at high frequency in the general population. Neurology. 2017 Jan 17; 88(3):334. PMID: 28093514.
      View in: PubMed
    15. Jankovic J. Movement disorders in 2016: Progress in Parkinson disease and other movement disorders. Nat Rev Neurol. 2017 Jan 13. PMID: 28084323.
      View in: PubMed
    16. Thenganatt MA, Jankovic J. Psychogenic (functional) parkinsonism. Handb Clin Neurol. 2017; 139:259-262. PMID: 27719845.
      View in: PubMed
    17. Baizabal-Carvallo JF, Jankovic J. Examiner manoeuvres 'sensory tricks' in functional (psychogenic) movement disorders. J Neurol Neurosurg Psychiatry. 2016 Dec 16. PMID: 27986829.
      View in: PubMed
    18. Bluett B, Litvan I, Cheng S, Juncos J, Riley DE, Standaert DG, Reich SG, Hall DA, Kluger B, Shprecher D, Marras C, Jankovic J. Understanding falls in progressive supranuclear palsy. Parkinsonism Relat Disord. 2016 Dec 15. PMID: 28007518.
      View in: PubMed
    19. Baizabal-Carvallo JF, Jankovic J. Distinguishing features of psychogenic (functional) versus organic hemifacial spasm. J Neurol. 2016 Dec 09. PMID: 27942912.
      View in: PubMed
    20. McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WL, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. 2017 Jan 10; 88(2):152-159. PMID: 27913695.
      View in: PubMed
    21. Jankovic J. Dopamine depleters in the treatment of hyperkinetic movement disorders. Expert Opin Pharmacother. 2016 Dec; 17(18):2461-2470. PMID: 27819145.
      View in: PubMed
    22. Jankovic J, Albanese A. Editorial: Toxins 2017. Toxicon. 2016 Dec 25; 123S:S1. PMID: 27889226.
      View in: PubMed
    23. Vijayakumar D, Wijemanne S, Jankovic J. Treatment of blepharospasm with apraclonidine. J Neurol Sci. 2017 Jan 15; 372:57-59. PMID: 28017248.
      View in: PubMed
    24. Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy T, Shprecher D, Stamler D. Deutetrabenazine in Tics Associated with Tourette Syndrome. Tremor Other Hyperkinet Mov (N Y). 2016; 6:422. PMID: 27917309.
      View in: PubMed
    25. Müller SH, Girard SL, Hopfner F, Merner ND, Bourassa CV, Lorenz D, Clark LN, Tittmann L, Soto-Ortolaza AI, Klebe S, Hallett M, Schneider SA, Hodgkinson CA, Lieb W, Wszolek ZK, Pendziwiat M, Lorenzo-Betancor O, Poewe W, Ortega-Cubero S, Seppi K, Rajput A, Hussl A, Rajput AH, Berg D, Dion PA, Wurster I, Shulman JM, Srulijes K, Haubenberger D, Pastor P, Vilariño-Güell C, Postuma RB, Bernard G, Ladwig KH, Dupré N, Jankovic J, Strauch K, Panisset M, Winkelmann J, Testa CM, Reischl E, Zeuner KE, Ross OA, Arzberger T, Chouinard S, Deuschl G, Louis ED, Kuhlenbäumer G, Rouleau GA. Genome-wide association study in essential tremor identifies three new loci. Brain. 2016 Dec; 139(Pt 12):3163-3169. PMID: 27797806.
      View in: PubMed
    26. Tröster AI, Jankovic J, Tagliati M, Peichel D, Okun MS. Neuropsychological outcomes from constant current deep brain stimulation for Parkinson's disease. Mov Disord. 2016 Oct 18. PMID: 27753157.
      View in: PubMed
    27. Oshima M, Deitiker P, Jankovic J, Atassi MZ. Submolecular recognition regions of the HN domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients. J Neuroimmunol. 2016 Nov 15; 300:36-46. PMID: 27806874.
      View in: PubMed
    28. Albanese A, Bhatia K, DeLong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Mink JW, Teller JK. "Complex" dystonia is not a category in the new 2013 consensus classification. Mov Disord. 2016 Nov; 31(11):1758-1759. PMID: 27612445.
      View in: PubMed
    29. Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial. JAMA. 2016 Jul 5; 316(1):40-50. PMID: 27380342.
      View in: PubMed
    30. Baizabal-Carvallo JF, Jankovic J. Functional (psychogenic) saccadic oscillations and oculogyric crises. Lancet Neurol. 2016 Jul; 15(8):791. PMID: 27302355.
      View in: PubMed
    31. Deng HX, Shi Y, Yang Y, Ahmeti KB, Miller N, Huang C, Cheng L, Zhai H, Deng S, Nuytemans K, Corbett NJ, Kim MJ, Deng H, Tang B, Yang Z, Xu Y, Chan P, Huang B, Gao XP, Song Z, Liu Z, Fecto F, Siddique N, Foroud T, Jankovic J, Ghetti B, Nicholson DA, Krainc D, Melen O, Vance JM, Pericak-Vance MA, Ma YC, Rajput AH, Siddique T. Identification of TMEM230 mutations in familial Parkinson's disease. Nat Genet. 2016 Jul; 48(7):733-9. PMID: 27270108.
      View in: PubMed
    32. Vijayakumar D, Jankovic J. Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia. Drugs. 2016 May; 76(7):779-87. PMID: 27091214.
      View in: PubMed
    33. Vijayakumar D, Jankovic J. Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia. Drugs. 2016 May; 76(7):759-77. PMID: 27091215.
      View in: PubMed
    34. Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, Armstrong MJ, Gloss D, Potrebic S, Jankovic J, Karp BP, Naumann M, So YT, Yablon SA. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016 May 10; 86(19):1818-26. PMID: 27164716; PMCID: PMC4862245 [Available on 05/10/17].
    35. LeDoux MS, Vemula SR, Xiao J, Thompson MM, Perlmutter JS, Wright LJ, Jinnah HA, Rosen AR, Hedera P, Comella CL, Weissbach A, Junker J, Jankovic J, Barbano RL, Reich SG, Rodriguez RL, Berman BD, Chouinard S, Severt L, Agarwal P, Stover NP. Clinical and genetic features of cervical dystonia in a large multicenter cohort. Neurol Genet. 2016 Jun; 2(3):e69. PMID: 27123488; PMCID: PMC4830199.
    36. Comella CL, Perlmutter JS, Jinnah HA, Waliczek TA, Rosen AR, Galpern WR, Adler CA, Barbano RL, Factor SA, Goetz CG, Jankovic J, Reich SG, Rodriguez RL, Severt WL, Zurowski M, Fox SH, Stebbins GT. Clinimetric testing of the comprehensive cervical dystonia rating scale. Mov Disord. 2016 Apr; 31(4):563-9. PMID: 26971359; PMCID: PMC4833533 [Available on 04/01/17].
    37. Baizabal-Carvallo JF, Jankovic J. Parkinsonism, movement disorders and genetics in frontotemporal dementia. Nat Rev Neurol. 2016 Mar; 12(3):175-85. PMID: 26891767.
      View in: PubMed
    38. Lotia M, Jankovic J. New and emerging medical therapies in Parkinson's disease. Expert Opin Pharmacother. 2016 May; 17(7):895-909. PMID: 26830844.
      View in: PubMed
    39. Lotia M, Jankovic J. Botulinum Toxin for the Treatment of Tremor and Tics. Semin Neurol. 2016 Feb; 36(1):54-63. PMID: 26866497.
      View in: PubMed
    40. Thenganatt MA, Jankovic J. Recent Advances in Understanding and Managing Tourette Syndrome. F1000Res. 2016; 5. PMID: 26918185; PMCID: PMC4755417.
    41. Baizabal-Carvallo JF, Jankovic J. Psychogenic Ophthalmologic Movement Disorders. J Neuropsychiatry Clin Neurosci. 2016; 28(3):195-8. PMID: 26792096.
      View in: PubMed
    42. Baizabal-Carvallo JF, Jankovic J. Movement disorders induced by deep brain stimulation. Parkinsonism Relat Disord. 2016 Apr; 25:1-9. PMID: 26806438.
      View in: PubMed
    43. Farlow JL, Robak LA, Hetrick K, Bowling K, Boerwinkle E, Coban-Akdemir ZH, Gambin T, Gibbs RA, Gu S, Jain P, Jankovic J, Jhangiani S, Kaw K, Lai D, Lin H, Ling H, Liu Y, Lupski JR, Muzny D, Porter P, Pugh E, White J, Doheny K, Myers RM, Shulman JM, Foroud T. Whole-Exome Sequencing in Familial Parkinson Disease. JAMA Neurol. 2016 Jan 1; 73(1):68-75. PMID: 26595808.
      View in: PubMed
    44. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. JAMA Neurol. 2016 Jan 1; 73(1):102-10. PMID: 26569098.
      View in: PubMed
    45. Molho ES, Stacy M, Gillard P, Charles D, Adler CH, Jankovic J, Schwartz M, Brin MF. Impact of Cervical Dystonia on Work Productivity: An Analysis From a Patient Registry. Mov Disord Clin Pract. 2016 Mar-Apr; 3(2):130-138. PMID: 27774495.
      View in: PubMed
    46. Oshima M, Deitiker P, Jankovic J, Aoki KR, Atassi MZ. Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients. Immunobiology. 2016 Apr; 221(4):568-76. PMID: 26701846.
      View in: PubMed
    47. Thenganatt MA, Jankovic J. Response to Shill and colleagues. Parkinsonism Relat Disord. 2016 Feb; 23:108. PMID: 26639977.
      View in: PubMed
    48. Wijemanne S, Jankovic J, Evans RW. Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine. Headache. 2016 Jan; 56(1):153-61. PMID: 26573884.
      View in: PubMed
    49. Ashoori A, Eagleman DM, Jankovic J. Effects of Auditory Rhythm and Music on Gait Disturbances in Parkinson's Disease. Front Neurol. 2015; 6:234. PMID: 26617566.
      View in: PubMed
    50. Jankovic J, Bressman S, Dauer W, Kang UJ. Clinical and scientific perspectives on movement disorders: Stanley Fahn's contributions. Mov Disord. 2015 Dec; 30(14):1862-9. PMID: 26477883.
      View in: PubMed
    51. Thenganatt MA, Jankovic J. The relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord. 2016 Jan; 22 Suppl 1:S162-5. PMID: 26522219.
      View in: PubMed
    52. Jankovic J. Therapeutic Developments for Tics and Myoclonus. Mov Disord. 2015 Sep 15; 30(11):1566-73. PMID: 26315614.
      View in: PubMed
    53. Schuff N, Wu IW, Buckley S, Foster ED, Coffey CS, Gitelman DR, Mendick S, Seibyl J, Simuni T, Zhang Y, Jankovic J, Hunter C, Tanner CM, Rees L, Factor S, Berg D, Wurster I, Gauss K, Sprenger F, Seppi K, Poewe W, Mollenhauer B, Knake S, Mari Z, McCoy A, Ranola M, Marek K. Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits. Mov Disord. 2015 Dec; 30(14):1885-92. PMID: 26260437.
      View in: PubMed
    54. Jankovic J. Leg stereotypy disorder. J Neurol Neurosurg Psychiatry. 2016 Feb; 87(2):220-1. PMID: 26209715.
      View in: PubMed
    55. Byrne S, Walsh C, Hacohen Y, Muscal E, Jankovic J, Stocco A, Dale RC, Vincent A, Lim M, King M. Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e130. PMID: 26236759.
      View in: PubMed
    56. Baizabal-Carvallo JF, Jankovic J. Speech and voice disorders in patients with psychogenic movement disorders. J Neurol. 2015 Nov; 262(11):2420-4. PMID: 26194199.
      View in: PubMed
    57. Waln O, Wu Y, Perlman R, Wendt J, Van AK, Jankovic J. Dopamine transporter imaging in essential tremor with and without parkinsonian features. J Neural Transm (Vienna). 2015 Nov; 122(11):1515-21. PMID: 26133163.
      View in: PubMed
    58. Feng Y, Liu T, Dong SY, Guo YJ, Jankovic J, Xu H, Wu YC. Rotenone affects p53 transcriptional activity and apoptosis via targeting SIRT1 and H3K9 acetylation in SH-SY5Y cells. J Neurochem. 2015 Aug; 134(4):668-76. PMID: 25991017.
      View in: PubMed
    59. Wijemanne S, Jankovic J. Dopa-responsive dystonia--clinical and genetic heterogeneity. Nat Rev Neurol. 2015 Jul; 11(7):414-24. PMID: 26100751.
      View in: PubMed
    60. Warren Olanow C, Bartus RT, Baumann TL, Factor S, Boulis N, Stacy M, Turner DA, Marks W, Larson P, Starr PA, Jankovic J, Simpson R, Watts R, Guthrie B, Poston K, Henderson JM, Stern M, Baltuch G, Goetz CG, Herzog C, Kordower JH, Alterman R, Lozano AM, Lang AE. Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. Ann Neurol. 2015 Aug; 78(2):248-57. PMID: 26061140.
      View in: PubMed
    61. Calleo JS, Amspoker AB, Sarwar AI, Kunik ME, Jankovic J, Marsh L, York M, Stanley MA. A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients With Parkinson Disease. J Geriatr Psychiatry Neurol. 2015 Sep; 28(3):210-7. PMID: 26047635.
      View in: PubMed
    62. Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, Tanner CM, Gilman S, Marshall FJ, Wooten F, Racette B, Chelimsky T, Singer W, Sletten DM, Sandroni P, Mandrekar J. Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol. 2015 Jul; 14(7):710-9. PMID: 26025783.
      View in: PubMed
    63. Deng H, Zheng W, Jankovic J. Genetics and molecular biology of brain calcification. Ageing Res Rev. 2015 Jul; 22:20-38. PMID: 25906927.
      View in: PubMed
    64. Jost WH, Benecke R, Hauschke D, Jankovic J, Ka?ovský P, Roggenkämper P, Simpson DM, Comella CL. Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders. Drug Des Devel Ther. 2015; 9:1913-26. PMID: 25897202; PMCID: PMC4389813.
    65. Wijemanne S, Jankovic J. Restless legs syndrome: clinical presentation diagnosis and treatment. Sleep Med. 2015 Jun; 16(6):678-90. PMID: 25979181.
      View in: PubMed
    66. Kluger B, Triolo P, Jones W, Jankovic J. The therapeutic potential of cannabinoids for movement disorders. Mov Disord. 2015 Mar; 30(3):313-27. PMID: 25649017; PMCID: PMC4357541.
    67. Jankovic J. Movement disorders. Neurol Clin. 2015 Feb; 33(1):xv-xvi. PMID: 25432734.
      View in: PubMed
    68. Waln O, Jankovic J. Paroxysmal movement disorders. Neurol Clin. 2015 Feb; 33(1):137-52. PMID: 25432727.
      View in: PubMed
    69. Thenganatt MA, Jankovic J. Psychogenic movement disorders. Neurol Clin. 2015 Feb; 33(1):205-24. PMID: 25432730.
      View in: PubMed
    70. Jankovic J. Gait disorders. Neurol Clin. 2015 Feb; 33(1):249-68. PMID: 25432732.
      View in: PubMed
    71. Baizabal-Carvallo JF, Xia G, Botros P, Laguna J, Ashizawa T, Jankovic J. Bolivian kindred with combined spinocerebellar ataxia types 2 and 10. Acta Neurol Scand. 2015 Aug; 132(2):139-42. PMID: 25630585.
      View in: PubMed
    72. Jankovic J, Adler CH, Charles D, Comella C, Stacy M, Schwartz M, Manack Adams A, Brin MF. Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE). J Neurol Sci. 2015 Feb 15; 349(1-2):84-93. PMID: 25595221.
      View in: PubMed
    73. Feng Y, Jankovic J, Wu YC. Epigenetic mechanisms in Parkinson's disease. J Neurol Sci. 2015 Feb 15; 349(1-2):3-9. PMID: 25553963.
      View in: PubMed
    74. Baizabal-Carvallo JF, Jankovic J. Stiff-person syndrome: insights into a complex autoimmune disorder. J Neurol Neurosurg Psychiatry. 2015 Aug; 86(8):840-8. PMID: 25511790.
      View in: PubMed
    75. Baizabal-Carvallo JF, Cardoso F, Jankovic J. Myorhythmia: phenomenology, etiology, and treatment. Mov Disord. 2015 Feb; 30(2):171-9. PMID: 25487777.
      View in: PubMed
    76. Inzelberg R, Hassin-Baer S, Jankovic J. Genetic movement disorders in patients of Jewish ancestry. JAMA Neurol. 2014 Dec; 71(12):1567-72. PMID: 25347348.
      View in: PubMed
    77. Fekete R, Jankovic J. Upper facial chorea in Huntington disease. J Clin Mov Disord. 2014; 1:7. PMID: 26788333.
      View in: PubMed
    78. Wijemanne S, Jankovic J. Movement disorders in catatonia. J Neurol Neurosurg Psychiatry. 2015 Aug; 86(8):825-32. PMID: 25411548.
      View in: PubMed
    79. Jankovic J, Sherer T. The future of research in Parkinson disease. JAMA Neurol. 2014 Nov; 71(11):1351-2. PMID: 25178587.
      View in: PubMed
    80. Yu D, Mathews CA, Scharf JM, Neale BM, Davis LK, Gamazon ER, Derks EM, Evans P, Edlund CK, Crane J, Fagerness JA, Osiecki L, Gallagher P, Gerber G, Haddad S, Illmann C, McGrath LM, Mayerfeld C, Arepalli S, Barlassina C, Barr CL, Bellodi L, Benarroch F, Berrió GB, Bienvenu OJ, Black DW, Bloch MH, Brentani H, Bruun RD, Budman CL, Camarena B, Campbell DD, Cappi C, Silgado JC, Cavallini MC, Chavira DA, Chouinard S, Cook EH, Cookson MR, Coric V, Cullen B, Cusi D, Delorme R, Denys D, Dion Y, Eapen V, Egberts K, Falkai P, Fernandez T, Fournier E, Garrido H, Geller D, Gilbert DL, Girard SL, Grabe HJ, Grados MA, Greenberg BD, Gross-Tsur V, Grünblatt E, Hardy J, Heiman GA, Hemmings SM, Herrera LD, Hezel DM, Hoekstra PJ, Jankovic J, Kennedy JL, King RA, Konkashbaev AI, Kremeyer B, Kurlan R, Lanzagorta N, Leboyer M, Leckman JF, Lennertz L, Liu C, Lochner C, Lowe TL, Lupoli S, Macciardi F, Maier W, Manunta P, Marconi M, McCracken JT, Mesa Restrepo SC, Moessner R, Moorjani P, Morgan J, Muller H, Murphy DL, Naarden AL, Nurmi E, Ochoa WC, Ophoff RA, Pakstis AJ, Pato MT, Pato CN, Piacentini J, Pittenger C, Pollak Y, Rauch SL, Renner T, Reus VI, Richter MA, Riddle MA, Robertson MM, Romero R, Rosário MC, Rosenberg D, Ruhrmann S, Sabatti C, Salvi E, Sampaio AS, Samuels J, Sandor P, Service SK, Sheppard B, Singer HS, Smit JH, Stein DJ, Strengman E, Tischfield JA, Turiel M, Valencia Duarte AV, Vallada H, Veenstra-VanderWeele J, Walitza S, Wang Y, Weale M, Weiss R, Wendland JR, Westenberg HG, Shugart YY, Hounie AG, Miguel EC, Nicolini H, Wagner M, Ruiz-Linares A, Cath DC, McMahon W, Posthuma D, Oostra BA, Nestadt G, Rouleau GA, Purcell S, Jenike MA, Heutink P, Hanna GL, Conti DV, Arnold PD, Freimer NB, Stewart SE, Knowles JA, Cox NJ, Pauls DL. Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry. 2015 Jan; 172(1):82-93. PMID: 25158072; PMCID: PMC4282594.
    81. Factor SA, Jankovic J. Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine. Neurology. 2014 Oct 7; 83(15):1388-9. PMID: 25288700.
      View in: PubMed
    82. Black KJ, Jankovic J, Hershey T, McNaught KS, Mink JW, Walkup J. Progress in research on Tourette syndrome. J Obsessive Compuls Relat Disord. 2014 Oct 01; 3(4):359-362. PMID: 25436182.
      View in: PubMed
    83. Giladi N, Ghys L, Surmann E, Boroojerdi B, Jankovic J. Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's disease. Parkinsonism Relat Disord. 2014 Dec; 20(12):1345-51. PMID: 25444083.
      View in: PubMed
    84. Jankovic J. "Psychogenic" versus "functional" movement disorders? That is the question. Mov Disord. 2014 Nov; 29(13):1697-8. PMID: 25255973.
      View in: PubMed
    85. Thenganatt MA, Jankovic J. Psychogenic tremor: a video guide to its distinguishing features. Tremor Other Hyperkinet Mov (N Y). 2014; 4:253. PMID: 25243097; PMCID: PMC4161970.
    86. Jankovic J, Roos RA. Chorea associated with Huntington's disease: to treat or not to treat? Mov Disord. 2014 Sep 15; 29(11):1414-8. PMID: 25156927.
      View in: PubMed
    87. Ramirez-Castaneda J, Jankovic J. Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up. Toxicon. 2014 Nov; 90:344-8. PMID: 25130293.
      View in: PubMed
    88. Evidente VG, Truong D, Jankovic J, Comella CL, Grafe S, Hanschmann A. IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated. J Neurol Sci. 2014 Nov 15; 346(1-2):116-20. PMID: 25186131.
      View in: PubMed
    89. Deng H, Xiu X, Jankovic J. Genetic convergence of Parkinson's disease and lysosomal storage disorders. Mol Neurobiol. 2015 Jun; 51(3):1554-68. PMID: 25099932.
      View in: PubMed
    90. Feng Y, Liu T, Li XQ, Liu Y, Zhu XY, Jankovic J, Pan TH, Wu YC. Neuroprotection by Orexin-A via HIF-1? induction in a cellular model of Parkinson's disease. Neurosci Lett. 2014 Sep 5; 579:35-40. PMID: 25038418.
      View in: PubMed
    91. Fernandez HH, Jankovic J, Holds JB, Lin D, Burns J, Verma A, Sethi K, Pappert EJ. Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm. Tremor Other Hyperkinet Mov (N Y). 2014; 4:238. PMID: 25120942; PMCID: PMC4107228.
    92. McGrath LM, Yu D, Marshall C, Davis LK, Thiruvahindrapuram B, Li B, Cappi C, Gerber G, Wolf A, Schroeder FA, Osiecki L, O'Dushlaine C, Kirby A, Illmann C, Haddad S, Gallagher P, Fagerness JA, Barr CL, Bellodi L, Benarroch F, Bienvenu OJ, Black DW, Bloch MH, Bruun RD, Budman CL, Camarena B, Cath DC, Cavallini MC, Chouinard S, Coric V, Cullen B, Delorme R, Denys D, Derks EM, Dion Y, Rosário MC, Eapen V, Evans P, Falkai P, Fernandez TV, Garrido H, Geller D, Grabe HJ, Grados MA, Greenberg BD, Gross-Tsur V, Grünblatt E, Heiman GA, Hemmings SM, Herrera LD, Hounie AG, Jankovic J, Kennedy JL, King RA, Kurlan R, Lanzagorta N, Leboyer M, Leckman JF, Lennertz L, Lochner C, Lowe TL, Lyon GJ, Macciardi F, Maier W, McCracken JT, McMahon W, Murphy DL, Naarden AL, Neale BM, Nurmi E, Pakstis AJ, Pato MT, Pato CN, Piacentini J, Pittenger C, Pollak Y, Reus VI, Richter MA, Riddle M, Robertson MM, Rosenberg D, Rouleau GA, Ruhrmann S, Sampaio AS, Samuels J, Sandor P, Sheppard B, Singer HS, Smit JH, Stein DJ, Tischfield JA, Vallada H, Veenstra-VanderWeele J, Walitza S, Wang Y, Wendland JR, Shugart YY, Miguel EC, Nicolini H, Oostra BA, Moessner R, Wagner M, Ruiz-Linares A, Heutink P, Nestadt G, Freimer N, Petryshen T, Posthuma D, Jenike MA, Cox NJ, Hanna GL, Brentani H, Scherer SW, Arnold PD, Stewart SE, Mathews CA, Knowles JA, Cook EH, Pauls DL, Wang K, Scharf JM. Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study. J Am Acad Child Adolesc Psychiatry. 2014 Aug; 53(8):910-9. PMID: 25062598; PMCID: PMC4218748.
    93. DiLorenzo DJ, Jankovic J, Simpson RK, Takei H, Powell SZ. Neurohistopathological findings at the electrode-tissue interface in long-term deep brain stimulation: systematic literature review, case report, and assessment of stimulation threshold safety. Neuromodulation. 2014 Jul; 17(5):405-18; discussion 418. PMID: 24947418.
      View in: PubMed
    94. Deng H, Gao K, Jankovic J. The role of FUS gene variants in neurodegenerative diseases. Nat Rev Neurol. 2014 Jun; 10(6):337-48. PMID: 24840975.
      View in: PubMed
    95. Goldman SM, Kamel F, Ross GW, Jewell SA, Marras C, Hoppin JA, Umbach DM, Bhudhikanok GS, Meng C, Korell M, Comyns K, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Sandler DP, Langston JW, Tanner CM. Peptidoglycan recognition protein genes and risk of Parkinson's disease. Mov Disord. 2014 Aug; 29(9):1171-80. PMID: 24838182; PMCID: PMC4777298.
    96. Patel N, Hanfelt J, Marsh L, Jankovic J. Alleviating manoeuvres (sensory tricks) in cervical dystonia. J Neurol Neurosurg Psychiatry. 2014 Aug; 85(8):882-4. PMID: 24828895; PMCID: PMC4871143.
    97. Charles PD, Adler CH, Stacy M, Comella C, Jankovic J, Manack Adams A, Schwartz M, Brin MF. Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy). J Neurol. 2014 Jul; 261(7):1309-19. PMID: 24752807; PMCID: PMC4098041.
    98. Thenganatt MA, Jankovic J. Parkinson disease subtypes. JAMA Neurol. 2014 Apr; 71(4):499-504. PMID: 24514863.
      View in: PubMed
    99. Jankovic J, Berkovich E, Eyal E, Tolosa E. Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: post-hoc analyses from the ADAGIO trial. Parkinsonism Relat Disord. 2014 Jun; 20(6):640-3. PMID: 24637126.
      View in: PubMed
    100. Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK. Reply: dystonia after severe head injuries. Mov Disord. 2014 Apr; 29(4):578-9. PMID: 24590449.
      View in: PubMed
    101. Thenganatt MA, Jankovic J. Treatment of dystonia. Neurotherapeutics. 2014 Jan; 11(1):139-52. PMID: 24142590; PMCID: PMC3899473.
    102. Galpern WR, Coffey CS, Albanese A, Cheung K, Comella CL, Ecklund DJ, Fahn S, Jankovic J, Kieburtz K, Lang AE, McDermott MP, Shefner JM, Teller JK, Thompson JL, Yeatts SD, Jinnah HA. Designing clinical trials for dystonia. Neurotherapeutics. 2014 Jan; 11(1):117-27. PMID: 24282121; PMCID: PMC3899487.
    103. Factor SA, Jankovic J. Editorial: Neurotherapeutics of movement disorders. Neurotherapeutics. 2014 Jan; 11(1):3-5. PMID: 24366609; PMCID: PMC3899485.
    104. Patel N, Jankovic J, Hallett M. Sensory aspects of movement disorders. Lancet Neurol. 2014 Jan; 13(1):100-12. PMID: 24331796; PMCID: PMC4759644.
    105. Le W, Sayana P, Jankovic J. Animal models of Parkinson's disease: a gateway to therapeutics? Neurotherapeutics. 2014 Jan; 11(1):92-110. PMID: 24158912; PMCID: PMC3899493.
    106. Baizabal-Carvallo JF, Jankovic J. The clinical features of psychogenic movement disorders resembling tics. J Neurol Neurosurg Psychiatry. 2014 May; 85(5):573-5. PMID: 24259592.
      View in: PubMed
    107. Defazio G, Jankovic J, Giel JL, Papapetropoulos S. Descriptive epidemiology of cervical dystonia. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 24255801; PMCID: PMC3822401.
    108. Davis LK, Yu D, Keenan CL, Gamazon ER, Konkashbaev AI, Derks EM, Neale BM, Yang J, Lee SH, Evans P, Barr CL, Bellodi L, Benarroch F, Berrio GB, Bienvenu OJ, Bloch MH, Blom RM, Bruun RD, Budman CL, Camarena B, Campbell D, Cappi C, Cardona Silgado JC, Cath DC, Cavallini MC, Chavira DA, Chouinard S, Conti DV, Cook EH, Coric V, Cullen BA, Deforce D, Delorme R, Dion Y, Edlund CK, Egberts K, Falkai P, Fernandez TV, Gallagher PJ, Garrido H, Geller D, Girard SL, Grabe HJ, Grados MA, Greenberg BD, Gross-Tsur V, Haddad S, Heiman GA, Hemmings SM, Hounie AG, Illmann C, Jankovic J, Jenike MA, Kennedy JL, King RA, Kremeyer B, Kurlan R, Lanzagorta N, Leboyer M, Leckman JF, Lennertz L, Liu C, Lochner C, Lowe TL, Macciardi F, McCracken JT, McGrath LM, Mesa Restrepo SC, Moessner R, Morgan J, Muller H, Murphy DL, Naarden AL, Ochoa WC, Ophoff RA, Osiecki L, Pakstis AJ, Pato MT, Pato CN, Piacentini J, Pittenger C, Pollak Y, Rauch SL, Renner TJ, Reus VI, Richter MA, Riddle MA, Robertson MM, Romero R, Rosàrio MC, Rosenberg D, Rouleau GA, Ruhrmann S, Ruiz-Linares A, Sampaio AS, Samuels J, Sandor P, Sheppard B, Singer HS, Smit JH, Stein DJ, Strengman E, Tischfield JA, Valencia Duarte AV, Vallada H, Van Nieuwerburgh F, Veenstra-Vanderweele J, Walitza S, Wang Y, Wendland JR, Westenberg HG, Shugart YY, Miguel EC, McMahon W, Wagner M, Nicolini H, Posthuma D, Hanna GL, Heutink P, Denys D, Arnold PD, Oostra BA, Nestadt G, Freimer NB, Pauls DL, Wray NR, Stewart SE, Mathews CA, Knowles JA, Cox NJ, Scharf JM. Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet. 2013 Oct; 9(10):e1003864. PMID: 24204291; PMCID: PMC3812053.
    109. Shen V, Clarence-Smith K, Hunter C, Jankovic J. Safety and Efficacy of Tetrabenazine and Use of Concomitant Medications During Long-Term, Open-Label Treatment of Chorea Associated with Huntington's and Other Diseases. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 24255799; PMCID: PMC3822048.
    110. Wijemanne S, Wu LJ, Jankovic J. Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome. Mov Disord. 2014 Jan; 29(1):126-30. PMID: 24150997.
      View in: PubMed
    111. Baizabal-Carvallo JF, Kagnoff MN, Jimenez-Shahed J, Fekete R, Jankovic J. The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond. J Neurol Neurosurg Psychiatry. 2014 May; 85(5):567-72. PMID: 24096713.
      View in: PubMed
    112. Patel AJ, Sarwar AI, Jankovic J, Viswanathan A. Bilateral pallidal deep brain stimulation for X-linked dystonia-parkinsonism. World Neurosurg. 2014 Jul-Aug; 82(1-2):241.e1-4. PMID: 24076056.
      View in: PubMed
    113. Strickland BA, Jimenez-Shahed J, Jankovic J, Viswanathan A. Radiofrequency lesioning through deep brain stimulation electrodes: a pilot study of lesion geometry and temperature characteristics. J Clin Neurosci. 2013 Dec; 20(12):1709-12. PMID: 24035651.
      View in: PubMed
    114. Pahwa R, Lyons KE, Hauser RA, Fahn S, Jankovic J, Pourcher E, Hsu A, O'Connell M, Kell S, Gupta S. Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease. Parkinsonism Relat Disord. 2014 Feb; 20(2):142-8. PMID: 24055014.
      View in: PubMed
    115. Mehanna R, Jankovic J. Restless legs syndrome and cerebrovascular disease - authors' reply. Lancet Neurol. 2013 Aug; 12(8):734-5. PMID: 23867192.
      View in: PubMed
    116. Ramirez-Castaneda J, Jankovic J, Comella C, Dashtipour K, Fernandez HH, Mari Z. Diffusion, spread, and migration of botulinum toxin. Mov Disord. 2013 Nov; 28(13):1775-83. PMID: 23868503.
      View in: PubMed
    117. Waln O, Jankovic J. An update on tardive dyskinesia: from phenomenology to treatment. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 23858394; PMCID: PMC3709416.
    118. Louis ED, Bain PG, Hallett M, Jankovic J, Vonsattel JP. What is It? Difficult to Pigeon Hole Tremor: a Clinical-Pathological Study of a Man with Jaw Tremor. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 23864988; PMCID: PMC3712322.
    119. Jankovic J. Medical treatment of dystonia. Mov Disord. 2013 Jun 15; 28(7):1001-12. PMID: 23893456.
      View in: PubMed
    120. Fernandez HH, Pagan F, Danisi F, Greeley D, Jankovic J, Verma A, Sethi K, Pappert EJ. Prospective Study Evaluating IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm: Interim Results from the First 145 Subjects with Cervical Dystonia. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 23724362; PMCID: PMC3638085.
    121. Baizabal-Carvallo JF, Jankovic J, Feld J. Flu-like symptoms and associated immunological response following therapy with botulinum toxins. Neurotox Res. 2013 Aug; 24(2):298-306. PMID: 23677449.
      View in: PubMed
    122. Baizabal-Carvallo JF, Jankovic J. Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism. Neuromodulation. 2014 Jan; 17(1):104-6. PMID: 23663196.
      View in: PubMed
    123. Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013 Jun 15; 28(7):863-73. PMID: 23649720; PMCID: PMC3729880.
    124. Waln O, Jankovic J. Zolpidem improves tardive dyskinesia and akathisia. Mov Disord. 2013 Oct; 28(12):1748-9. PMID: 23637028.
      View in: PubMed
    125. Killoran A, Biglan KM, Jankovic J, Eberly S, Kayson E, Oakes D, Young AB, Shoulson I. Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS. Neurology. 2013 May 28; 80(22):2022-7. PMID: 23624566; PMCID: PMC3716408.
    126. Mehanna R, Jankovic J. Movement disorders in cerebrovascular disease. Lancet Neurol. 2013 Jun; 12(6):597-608. PMID: 23602779.
      View in: PubMed
    127. Fernandez HH, Pappert EJ, Comella CL, Evidente VG, Truong DD, Verma A, Jankovic J. Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Naïve Subjects with Cervical Dystonia. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 23610743; PMCID: PMC3629862.
    128. Baizabal-Carvallo JF, Bonnet C, Jankovic J. Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome. J Neural Transm (Vienna). 2013 Nov; 120(11):1579-89. PMID: 23580159.
      View in: PubMed
    129. Waln O, Jankovic J. Bilateral globus pallidus internus deep brain stimulation after bilateral pallidotomy in a patient with generalized early-onset primary dystonia. Mov Disord. 2013 Jul; 28(8):1162-3. PMID: 23580321.
      View in: PubMed
    130. Deng H, Gao K, Jankovic J. The VPS35 gene and Parkinson's disease. Mov Disord. 2013 May; 28(5):569-75. PMID: 23536430.
      View in: PubMed
    131. Dhungana S, Jankovic J. Yips and other movement disorders in golfers. Mov Disord. 2013 May; 28(5):576-81. PMID: 23519739.
      View in: PubMed
    132. Mehanna R, Jankovic J. Movement disorders in multiple sclerosis and other demyelinating diseases. J Neurol Sci. 2013 May 15; 328(1-2):1-8. PMID: 23522528.
      View in: PubMed
    133. Truong DD, Gollomp SM, Jankovic J, LeWitt PA, Marx M, Hanschmann A, Fernandez HH. Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm. J Neural Transm (Vienna). 2013 Sep; 120(9):1345-53. PMID: 23435927; PMCID: PMC3751217.
    134. Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale. Mov Disord. 2013 May; 28(5):668-70. PMID: 23408503.
      View in: PubMed
    135. Baizabal-Carvallo JF, Stocco A, Muscal E, Jankovic J. The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord. 2013 Apr; 28(4):543-7. PMID: 23400857.
      View in: PubMed
    136. Hallett M, Albanese A, Dressler D, Segal KR, Simpson DM, Truong D, Jankovic J. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon. 2013 Jun 1; 67:94-114. PMID: 23380701.
      View in: PubMed
    137. Ramirez-Castaneda J, Jankovic J. Long-term efficacy and safety of botulinum toxin injections in dystonia. Toxins (Basel). 2013 Feb; 5(2):249-66. PMID: 23381141; PMCID: PMC3640534.
    138. Deng H, Liang H, Jankovic J. F-box only protein 7 gene in parkinsonian-pyramidal disease. JAMA Neurol. 2013 Jan; 70(1):20-4. PMID: 23318512.
      View in: PubMed
    139. Schneider SA, Dusek P, Hardy J, Westenberger A, Jankovic J, Bhatia KP. Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA). Curr Neuropharmacol. 2013 Jan; 11(1):59-79. PMID: 23814539; PMCID: PMC3580793.
    140. Mehanna R, Hunter C, Davidson A, Jimenez-Shahed J, Jankovic J. Analysis of CYP2D6 genotype and response to tetrabenazine. Mov Disord. 2013 Feb; 28(2):210-5. PMID: 23280482.
      View in: PubMed
    141. Mehanna R, Jankovic J. Respiratory disorders associated with dystonia. Mov Disord. 2012 Dec; 27(14):1816-9. PMID: 23208724.
      View in: PubMed
    142. Naumann M, Dressler D, Hallett M, Jankovic J, Schiavo G, Segal KR, Truong D. Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders. Toxicon. 2013 Jun 1; 67:141-52. PMID: 23178324.
      View in: PubMed
    143. Baizabal-Carvallo JF, Jankovic J. Spinocerebellar ataxia types 2 and 10: more than a coincidental association? Arch Neurol. 2012 Nov; 69(11):1524-5; Author reply 1525. PMID: 23117922.
      View in: PubMed
    144. Elble R, Comella C, Fahn S, Hallett M, Jankovic J, Juncos JL, Lewitt P, Lyons K, Ondo W, Pahwa R, Sethi K, Stover N, Tarsy D, Testa C, Tintner R, Watts R, Zesiewicz T. Reliability of a new scale for essential tremor. Mov Disord. 2012 Oct; 27(12):1567-9. PMID: 23032792; PMCID: PMC4157921.
    145. Ferrara JM, Mostile G, Hunter C, Adam OR, Jankovic J. Effect of tetrabenazine on motor function in patients with huntington disease. Neurol Ther. 2012 Dec; 1(1):5. PMID: 26000211; PMCID: PMC4389035.
    146. Squitieri F, Jankovic J. Huntington's disease: how intermediate are intermediate repeat lengths? Mov Disord. 2012 Dec; 27(14):1714-7. PMID: 23008174.
      View in: PubMed
    147. Pan T, Zhu J, Hwu WJ, Jankovic J. The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells. PLoS One. 2012; 7(9):e45183. PMID: 23028833; PMCID: PMC3446957.
    148. Ondo WG, Jankovic J, Simpson R, Jimenez-Shahed J. Globus pallidus deep brain stimulation for refractory idiopathic restless legs syndrome. Sleep Med. 2012 Oct; 13(9):1202-4. PMID: 22995627.
      View in: PubMed
    149. Zhang Z, Li X, Xie WJ, Tuo H, Hintermann S, Jankovic J, Le W. Anti-parkinsonian effects of Nurr1 activator in ubiquitin-proteasome system impairment induced animal model of Parkinson's disease. CNS Neurol Disord Drug Targets. 2012 Sep; 11(6):768-73. PMID: 22483304.
      View in: PubMed
    150. Guo Y, Deng X, Jankovic J, Su L, Zhang J, Le W, Xu H, Yang Z, Tang J, Kuang S, Deng H. Mutation screening of the HTR2B gene in patients with Tourette syndrome. Neurosci Lett. 2012 Sep 27; 526(2):150-3. PMID: 22917605.
      View in: PubMed
    151. Fekete R, Davidson A, Jankovic J. Clinical assessment of the effect of tetrabenazine on functional scales in huntington disease: a pilot open label study. Tremor Other Hyperkinet Mov (N Y). 2012; 2. PMID: 23439575; PMCID: PMC3569975.
    152. Jankovic J. Current concepts in Parkinson's disease and other movement disorders. Curr Opin Neurol. 2012 Aug; 25(4):429-32. PMID: 22772873.
      View in: PubMed
    153. Poewe W, Mahlknecht P, Jankovic J. Emerging therapies for Parkinson's disease. Curr Opin Neurol. 2012 Aug; 25(4):448-59. PMID: 22772874.
      View in: PubMed
    154. Jankovic J, Poewe W. Therapies in Parkinson's disease. Curr Opin Neurol. 2012 Aug; 25(4):433-47. PMID: 22691758.
      View in: PubMed
    155. Baizabal Carvallo JF, Mostile G, Almaguer M, Davidson A, Simpson R, Jankovic J. Deep brain stimulation hardware complications in patients with movement disorders: risk factors and clinical correlations. Stereotact Funct Neurosurg. 2012; 90(5):300-6. PMID: 22797749.
      View in: PubMed
    156. Kansara S, Trivedi A, Chen S, Jankovic J, Le W. Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed? J Neural Transm (Vienna). 2013 Jan; 120(1):197-210. PMID: 22733089.
      View in: PubMed
    157. Viswanathan A, Jimenez-Shahed J, Baizabal Carvallo JF, Jankovic J. Deep brain stimulation for Tourette syndrome: target selection. Stereotact Funct Neurosurg. 2012; 90(4):213-24. PMID: 22699684.
      View in: PubMed
    158. Fekete R, Jankovic J. Childhood stiff-person syndrome improved with rituximab. Case Rep Neurol. 2012 May; 4(2):92-6. PMID: 22740823; PMCID: PMC3383307.
    159. Marshall DF, Strutt AM, Williams AE, Simpson RK, Jankovic J, York MK. Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Eur J Neurol. 2012 Dec; 19(12):1525-31. PMID: 22632922.
      View in: PubMed
    160. Mostile G, Fekete R, Giuffrida JP, Yaltho T, Davidson A, Nicoletti A, Zappia M, Jankovic J. Amplitude fluctuations in essential tremor. Parkinsonism Relat Disord. 2012 Aug; 18(7):859-63. PMID: 22591578.
      View in: PubMed
    161. Baizabal-Carvallo JF, Jankovic J. Movement disorders in autoimmune diseases. Mov Disord. 2012 Jul; 27(8):935-46. PMID: 22555904.
      View in: PubMed
    162. Deng H, Gao K, Jankovic J. The genetics of Tourette syndrome. Nat Rev Neurol. 2012 Apr; 8(4):203-13. PMID: 22410579.
      View in: PubMed
    163. Elmer LW, Surmann E, Boroojerdi B, Jankovic J. Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: a prospective, open-label extension study. Parkinsonism Relat Disord. 2012 Jun; 18(5):488-93. PMID: 22326237.
      View in: PubMed
    164. Ha AD, Beck CA, Jankovic J. Intermediate CAG Repeats in Huntington's Disease: Analysis of COHORT. Tremor Other Hyperkinet Mov (N Y). 2012; 2. PMID: 23440000; PMCID: PMC3569951.
    165. Li XP, Xie WJ, Zhang Z, Kansara S, Jankovic J, Le WD. A mechanistic study of proteasome inhibition-induced iron misregulation in dopamine neuron degeneration. Neurosignals. 2012; 20(4):223-36. PMID: 22269801.
      View in: PubMed
    166. Dusek P, Jankovic J, Le W. Iron dysregulation in movement disorders. Neurobiol Dis. 2012 Apr; 46(1):1-18. PMID: 22266337.
      View in: PubMed
    167. Okun MS, Gallo BV, Mandybur G, Jagid J, Foote KD, Revilla FJ, Alterman R, Jankovic J, Simpson R, Junn F, Verhagen L, Arle JE, Ford B, Goodman RR, Stewart RM, Horn S, Baltuch GH, Kopell BH, Marshall F, Peichel D, Pahwa R, Lyons KE, Tröster AI, Vitek JL, Tagliati M. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. Lancet Neurol. 2012 Feb; 11(2):140-9. PMID: 22239915.
      View in: PubMed
    168. Goldman SM, Kamel F, Ross GW, Jewell SA, Bhudhikanok GS, Umbach D, Marras C, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Meng C, Korell M, Roucoux DF, Hoppin JA, Sandler DP, Langston JW, Tanner CM. Head injury, ?-synuclein Rep1, and Parkinson's disease. Ann Neurol. 2012 Jan; 71(1):40-8. PMID: 22275250; PMCID: PMC3270814.
    169. Lee HY, Huang Y, Bruneau N, Roll P, Roberson ED, Hermann M, Quinn E, Maas J, Edwards R, Ashizawa T, Baykan B, Bhatia K, Bressman S, Bruno MK, Brunt ER, Caraballo R, Echenne B, Fejerman N, Frucht S, Gurnett CA, Hirsch E, Houlden H, Jankovic J, Lee WL, Lynch DR, Mohammed S, Müller U, Nespeca MP, Renner D, Rochette J, Rudolf G, Saiki S, Soong BW, Swoboda KJ, Tucker S, Wood N, Hanna M, Bowcock AM, Szepetowski P, Fu YH, Ptá?ek LJ. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep. 2012 Jan 26; 1(1):2-12. PMID: 22832103; PMCID: PMC3334308.
    170. Lees A, Fahn S, Eggert KM, Jankovic J, Lang A, Micheli F, Mouradian MM, Oertel WH, Olanow CW, Poewe W, Rascol O, Tolosa E, Squillacote D, Kumar D. Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease. Mov Disord. 2012 Feb; 27(2):284-8. PMID: 22161845.
      View in: PubMed
    171. Oshima M, Deitiker PR, Jankovic J, Duane DD, Aoki KR, Atassi MZ. Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B. J Neuroimmunol. 2011 Dec 15; 240-241:121-8. PMID: 22079193.
      View in: PubMed
    172. Jankovic J, Adler CH, Charles PD, Comella C, Stacy M, Schwartz M, Sutch SM, Brin MF, Papapetropoulos S. Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE). BMC Neurol. 2011; 11:140. PMID: 22054223; PMCID: PMC3220636.
    173. Jankovic J, Clarence-Smith K. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders. Expert Rev Neurother. 2011 Nov; 11(11):1509-23. PMID: 22014129.
      View in: PubMed
    174. Patel SS, Jankovic J, Hood AJ, Jeter CB, Sereno AB. Reflexive and volitional saccades: biomarkers of Huntington disease severity and progression. J Neurol Sci. 2012 Feb 15; 313(1-2):35-41. PMID: 22018763; PMCID: PMC3254798.
    175. Ha AD, Jankovic J. Pain in Parkinson's disease. Mov Disord. 2012 Apr; 27(4):485-91. PMID: 21953990.
      View in: PubMed
    176. Fekete R, Baizabal-Carvallo JF, Ha AD, Davidson A, Jankovic J. Convergence spasm in conversion disorders: prevalence in psychogenic and other movement disorders compared with controls. J Neurol Neurosurg Psychiatry. 2012 Feb; 83(2):202-4. PMID: 21949106.
      View in: PubMed
    177. Jankovic J. Diagnosis and treatment of psychogenic parkinsonism. J Neurol Neurosurg Psychiatry. 2011 Dec; 82(12):1300-3. PMID: 21933950.
      View in: PubMed
    178. Ha AD, Brown CH, York MK, Jankovic J. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsonism Relat Disord. 2011 Sep; 17(8):625-8. PMID: 21689962.
      View in: PubMed
    179. Ha AD, Jankovic J. Exploring the correlates of intermediate CAG repeats in Huntington disease. Postgrad Med. 2011 Sep; 123(5):116-21. PMID: 21904093.
      View in: PubMed
    180. Atassi MZ, Jankovic J, Steward LE, Aoki KR, Dolimbek BZ. Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule. Immunobiology. 2012 Jan; 217(1):17-27. PMID: 21962573.
      View in: PubMed
    181. Wu Y, Li X, Zhu JX, Xie W, Le W, Fan Z, Jankovic J, Pan T. Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson's disease. Neurosignals. 2011; 19(3):163-74. PMID: 21778691; PMCID: PMC3699815.
    182. Comella CL, Jankovic J, Truong DD, Hanschmann A, Grafe S. Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia. J Neurol Sci. 2011 Sep 15; 308(1-2):103-9. PMID: 21764407.
      View in: PubMed
    183. Oshima M, Deitiker PR, Jankovic J, Duane DD, Aoki KR, Atassi MZ. Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patients. J Neuroimmunol. 2011 Aug 15; 237(1-2):66-72. PMID: 21737146.
      View in: PubMed
    184. Baizabal Carvallo JF, Simpson R, Jankovic J. Diagnosis and treatment of complications related to deep brain stimulation hardware. Mov Disord. 2011 Jul; 26(8):1398-406. PMID: 21714001.
      View in: PubMed
    185. Strutt AM, Simpson R, Jankovic J, York MK. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease. Eur J Neurol. 2012 Jan; 19(1):121-7. PMID: 21668586.
      View in: PubMed
    186. Baizabal-Carvallo JF, Jankovic J, Pappert E. Flu-like symptoms following botulinum toxin therapy. Toxicon. 2011 Jul; 58(1):1-7. PMID: 21620881.
      View in: PubMed
    187. Heldman DA, Jankovic J, Vaillancourt DE, Prodoehl J, Elble RJ, Giuffrida JP. Essential tremor quantification during activities of daily living. Parkinsonism Relat Disord. 2011 Aug; 17(7):537-42. PMID: 21570891; PMCID: PMC3137659.
    188. Jankovic J, Comella C, Hanschmann A, Grafe S. Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial. Mov Disord. 2011 Jul; 26(8):1521-8. PMID: 21520284.
      View in: PubMed
    189. van Rooijen DE, Geraedts EJ, Marinus J, Jankovic J, van Hilten JJ. Peripheral trauma and movement disorders: a systematic review of reported cases. J Neurol Neurosurg Psychiatry. 2011 Aug; 82(8):892-8. PMID: 21493756.
      View in: PubMed
    190. Ha AD, Jankovic J. Parkinsonism and dystonia associated with adalimumab. Mov Disord. 2011 Jul; 26(8):1556-8. PMID: 21495070.
      View in: PubMed
    191. Jankovic J, Kurlan R. Tourette syndrome: evolving concepts. Mov Disord. 2011 May; 26(6):1149-56. PMID: 21484868.
      View in: PubMed
    192. Rascol O, Fitzer-Attas CJ, Hauser R, Jankovic J, Lang A, Langston JW, Melamed E, Poewe W, Stocchi F, Tolosa E, Eyal E, Weiss YM, Olanow CW. A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. Lancet Neurol. 2011 May; 10(5):415-23. PMID: 21482191.
      View in: PubMed
    193. Yaltho TC, Jankovic J. The many faces of hemifacial spasm: differential diagnosis of unilateral facial spasms. Mov Disord. 2011 Aug 1; 26(9):1582-92. PMID: 21469208.
      View in: PubMed
    194. Guo Y, Le WD, Jankovic J, Yang HR, Xu HB, Xie WJ, Song Z, Deng H. Systematic genetic analysis of the PITX3 gene in patients with Parkinson disease. Mov Disord. 2011 Aug 1; 26(9):1729-32. PMID: 21469209.
      View in: PubMed
    195. Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Edwards KL, Snapinn KW, Goldstein DS, Shi M, Zhang J. Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy. Am J Pathol. 2011 Apr; 178(4):1509-16. PMID: 21435440; PMCID: PMC3078443.
    196. Pan T, Li X, Jankovic J. The association between Parkinson's disease and melanoma. Int J Cancer. 2011 May 15; 128(10):2251-60. PMID: 21207412.
      View in: PubMed
    197. Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, Wang Y, Aasly J, Goldstein D, Zhang J. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol. 2011 Mar; 69(3):570-80. PMID: 21400565; PMCID: PMC3117674.
    198. Squitieri F, Esmaeilzadeh M, Ciarmiello A, Jankovic J. Caudate glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG(33) repeat length in the Huntington's disease gene. Mov Disord. 2011 Apr; 26(5):925-7. PMID: 21370274.
      View in: PubMed
    199. Fekete R, Jankovic J. Revisiting the relationship between essential tremor and Parkinson's disease. Mov Disord. 2011 Feb 15; 26(3):391-8. PMID: 21462256.
      View in: PubMed
    200. Williams AE, Arzola GM, Strutt AM, Simpson R, Jankovic J, York MK. Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord. 2011 Jun; 17(5):321-7. PMID: 21316292; PMCID: PMC3109216.
    201. Ha AD, Jankovic J. An introduction to dyskinesia--the clinical spectrum. Int Rev Neurobiol. 2011; 98:1-29. PMID: 21907081.
      View in: PubMed
    202. Wu Y, Le W, Jankovic J. Preclinical biomarkers of Parkinson disease. Arch Neurol. 2011 Jan; 68(1):22-30. PMID: 21220674.
      View in: PubMed
    203. Ferrara J, Stamey W, Strutt AM, Adam OR, Jankovic J. Transcutaneous electrical stimulation (TENS) for psychogenic movement disorders. J Neuropsychiatry Clin Neurosci. 2011; 23(2):141-8. PMID: 21677241.
      View in: PubMed
    204. Atassi MZ, Dolimbek BZ, Jankovic J, Steward LE, Aoki KR. Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies. Immunobiology. 2011 Jul; 216(7):782-92. PMID: 21281977.
      View in: PubMed
    205. Li X, Jankovic J, Le W. Iron chelation and neuroprotection in neurodegenerative diseases. J Neural Transm (Vienna). 2011 Mar; 118(3):473-7. PMID: 21161300.
      View in: PubMed
    206. Montine TJ, Shi M, Quinn JF, Peskind ER, Craft S, Ginghina C, Chung KA, Kim H, Galasko DR, Jankovic J, Zabetian CP, Leverenz JB, Zhang J. CSF A?(42) and tau in Parkinson's disease with cognitive impairment. Mov Disord. 2010 Nov 15; 25(15):2682-5. PMID: 20818673; PMCID: PMC2978754.
    207. Wu Y, Davidson AL, Pan T, Jankovic J. Asian over-representation among patients with hemifacial spasm compared to patients with cranial-cervical dystonia. J Neurol Sci. 2010 Nov 15; 298(1-2):61-3. PMID: 20864122.
      View in: PubMed
    208. Yaltho TC, Jankovic J, Lotze T. The association of Tourette syndrome and dopa-responsive dystonia. Mov Disord. 2011 Feb 1; 26(2):359-60. PMID: 21412842.
      View in: PubMed
    209. Mostile G, Jankovic J. Alcohol in essential tremor and other movement disorders. Mov Disord. 2010 Oct 30; 25(14):2274-84. PMID: 20721919.
      View in: PubMed
    210. Ondo WG, Adam OR, Jankovic J, Chinnery PF. Dramatic response of facial stereotype/tic to tetrabenazine in the first reported cases of neuroferritinopathy in the United States. Mov Disord. 2010 Oct 30; 25(14):2470-2. PMID: 20818611.
      View in: PubMed
    211. Marks WJ, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M, Turner D, Verhagen L, Bakay R, Watts R, Guthrie B, Jankovic J, Simpson R, Tagliati M, Alterman R, Stern M, Baltuch G, Starr PA, Larson PS, Ostrem JL, Nutt J, Kieburtz K, Kordower JH, Olanow CW. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol. 2010 Dec; 9(12):1164-72. PMID: 20970382.
      View in: PubMed
    212. Jankovic J, Gelineau-Kattner R, Davidson A. Tourette's syndrome in adults. Mov Disord. 2010 Oct 15; 25(13):2171-5. PMID: 20690167.
      View in: PubMed
    213. Guo Y, Jankovic J, Song Z, Yang H, Zheng W, Le W, Tang X, Deng X, Yang Y, Deng S, Luo Z, Deng H. LINGO1 rs9652490 variant in Parkinson disease patients. Neurosci Lett. 2011 Jan 7; 487(2):174-6. PMID: 20951767.
      View in: PubMed
    214. Deitiker PR, Oshima M, Jankovic J, Duane DD, Aoki KR, Atassi MZ. Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian Americans. Autoimmunity. 2011 May; 44(3):167-76. PMID: 20843162.
      View in: PubMed
    215. Mostile G, Giuffrida JP, Adam OR, Davidson A, Jankovic J. Correlation between Kinesia system assessments and clinical tremor scores in patients with essential tremor. Mov Disord. 2010 Sep 15; 25(12):1938-43. PMID: 20623687.
      View in: PubMed
    216. Peña MS, Yaltho TC, Jankovic J. Tardive dyskinesia and other movement disorders secondary to aripiprazole. Mov Disord. 2011 Jan; 26(1):147-52. PMID: 20818603.
      View in: PubMed
    217. Xie W, Li X, Li C, Zhu W, Jankovic J, Le W. Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease. J Neurochem. 2010 Oct; 115(1):188-99. PMID: 20649845.
      View in: PubMed
    218. Mehanna R, Jankovic J. Respiratory problems in neurologic movement disorders. Parkinsonism Relat Disord. 2010 Dec; 16(10):628-38. PMID: 20674459.
      View in: PubMed
    219. Lim J, Sanghera MK, Darbin O, Stewart RM, Jankovic J, Simpson R. Nonlinear temporal organization of neuronal discharge in the basal ganglia of Parkinson's disease patients. Exp Neurol. 2010 Aug; 224(2):542-4. PMID: 20653074.
      View in: PubMed
    220. Stocchi F, Rascol O, Kieburtz K, Poewe W, Jankovic J, Tolosa E, Barone P, Lang AE, Olanow CW. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study. Ann Neurol. 2010 Jul; 68(1):18-27. PMID: 20582993.
      View in: PubMed
    221. Shi M, Zabetian CP, Hancock AM, Ginghina C, Hong Z, Yearout D, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Leverenz JB, Zhang J. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. Neurosci Lett. 2010 Aug 9; 480(1):78-82. PMID: 20540987; PMCID: PMC2943649.
    222. Mejia NI, Jankovic J. Tardive dyskinesia and withdrawal emergent syndrome in children. Expert Rev Neurother. 2010 Jun; 10(6):893-901. PMID: 20518606.
      View in: PubMed
    223. Lim J, Sanghera MK, Darbin O, Stewart RM, Jankovic J, Simpson R. Nonlinear temporal organization of neuronal discharge in the basal ganglia of Parkinson's disease patients. Exp Neurol. 2010 May 28. PMID: 20685206.
      View in: PubMed
    224. Wu Y, Li X, Xie W, Jankovic J, Le W, Pan T. Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1 alpha and induction of autophagy in SH-SY5Y cells. Neurochem Int. 2010 Oct; 57(3):198-205. PMID: 20546814.
      View in: PubMed
    225. Okun MS, Lang A, Jankovic J. Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease. Mov Disord. 2010 May 15; 25(7):961-2; author reply 962-3. PMID: 20461816.
      View in: PubMed
    226. Tan EK, Peng R, Teo YY, Tan LC, Angeles D, Ho P, Chen ML, Lin CH, Mao XY, Chang XL, Prakash KM, Liu JJ, Au WL, Le WD, Jankovic J, Burgunder JM, Zhao Y, Wu RM. Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study. Hum Mutat. 2010 May; 31(5):561-8. PMID: 20186690.
      View in: PubMed
    227. Jankovic J. Camptocormia, head drop and other bent spine syndromes: heterogeneous etiology and pathogenesis of Parkinsonian deformities. Mov Disord. 2010 Apr 15; 25(5):527-8. PMID: 20425791.
      View in: PubMed
    228. Vilariño-Güell C, Wider C, Ross OA, Jasinska-Myga B, Kachergus J, Cobb SA, Soto-Ortolaza AI, Behrouz B, Heckman MG, Diehl NN, Testa CM, Wszolek ZK, Uitti RJ, Jankovic J, Louis ED, Clark LN, Rajput A, Farrer MJ. LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics. 2010 Oct; 11(4):401-8. PMID: 20369371; PMCID: PMC3930084.
    229. Truong D, Brodsky M, Lew M, Brashear A, Jankovic J, Molho E, Orlova O, Timerbaeva S. Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia. Parkinsonism Relat Disord. 2010 Jun; 16(5):316-23. PMID: 20359934.
      View in: PubMed
    230. Frank S, Jankovic J. Advances in the pharmacological management of Huntington's disease. Drugs. 2010 Mar 26; 70(5):561-71. PMID: 20329804.
      View in: PubMed
    231. Fekete R, Jankovic J. Psychogenic chorea associated with family history of Huntington disease. Mov Disord. 2010 Mar 15; 25(4):503-4. PMID: 20063405.
      View in: PubMed
    232. Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain. 2010 Mar; 133(Pt 3):713-26. PMID: 20157014; PMCID: PMC2842513.
    233. DiLorenzo DJ, Jankovic J, Simpson RK, Takei H, Powell SZ. Long-term deep brain stimulation for essential tremor: 12-year clinicopathologic follow-up. Mov Disord. 2010 Jan 30; 25(2):232-8. PMID: 20063387.
      View in: PubMed
    234. Deng H, Yang H, Le W, Deng X, Xu H, Xiong W, Zhu S, Xie W, Song Z, Jankovic J. Examination of the MASH1 gene in patients with Parkinson's disease. Biochem Biophys Res Commun. 2010 Feb 19; 392(4):548-50. PMID: 20097173.
      View in: PubMed
    235. Hwang H, Zhang J, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, Jankovic J, Su Z, Hancock AM, Pan C, Montine TJ, Pan S, Nutt J, Albin R, Gearing M, Beyer RP, Shi M, Zhang J. Glycoproteomics in neurodegenerative diseases. Mass Spectrom Rev. 2010 Jan-Feb; 29(1):79-125. PMID: 19358229; PMCID: PMC2799547.
    236. Deng H, Zhu SH, Le WD, Yang HR, Lv HW, Xu HB, Xie WJ, Jankovic J. Examination of the MSX1 gene in patients with Parkinson's disease. Acta Neurol Scand. 2009 Dec; 120(6):442-4. PMID: 19922584.
      View in: PubMed
    237. Jankovic J. Clinical efficacy and tolerability of Xeomin in the treatment of blepharospasm. Eur J Neurol. 2009 Dec; 16 Suppl 2:14-8. PMID: 20002742.
      View in: PubMed
    238. Mostile G, Jankovic J. Treatment of dysautonomia associated with Parkinson's disease. Parkinsonism Relat Disord. 2009 Dec; 15 Suppl 3:S224-32. PMID: 20082997.
      View in: PubMed
    239. Deng S, Deng H, Le W, Xu H, Yang H, Deng X, Lv H, Xie W, Zhu S, Jankovic J. Genetic analysis of the NEUROG2 gene in patients with Parkinson's disease. Neurosci Lett. 2010 Jan 14; 468(3):195-7. PMID: 19879328.
      View in: PubMed
    240. Adam OR, Ferrara JM, Jankovic J. Motor-phonic tic mimicking essential palatal myoclonus. Mov Disord. 2009 Oct 15; 24(13):2030-2. PMID: 19672987.
      View in: PubMed
    241. Zhu W, Li X, Xie W, Luo F, Kaur D, Andersen JK, Jankovic J, Le W. Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration. Neurobiol Dis. 2010 Feb; 37(2):307-13. PMID: 19818853.
      View in: PubMed
    242. Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, Langston W, Melamed E, Poewe W, Stocchi F, Tolosa E. A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med. 2009 Sep 24; 361(13):1268-78. PMID: 19776408.
      View in: PubMed
    243. York MK, Wilde EA, Simpson R, Jankovic J. Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location. J Neurol Sci. 2009 Dec 15; 287(1-2):159-71. PMID: 19767016; PMCID: PMC2783787.
    244. Adam OR, Ferrara JM, Aguilar Tabora LG, Nashatizadeh MM, Negoita M, Jankovic J. Education research: patient telephone calls in a movement disorders center: lessons in physician-trainee education. Neurology. 2009 Sep 8; 73(10):e50-2. PMID: 19738167.
      View in: PubMed
    245. Tanner CM, Ross GW, Jewell SA, Hauser RA, Jankovic J, Factor SA, Bressman S, Deligtisch A, Marras C, Lyons KE, Bhudhikanok GS, Roucoux DF, Meng C, Abbott RD, Langston JW. Occupation and risk of parkinsonism: a multicenter case-control study. Arch Neurol. 2009 Sep; 66(9):1106-13. PMID: 19752299.
      View in: PubMed
    246. Ferrara J, Diamond A, Hunter C, Davidson A, Almaguer M, Jankovic J. Impact of STN-DBS on life and health satisfaction in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2010 Mar; 81(3):315-9. PMID: 19726415.
      View in: PubMed
    247. Jankovic J, Jimenez-Shahed J, Brown LW. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry. 2010 Jan; 81(1):70-3. PMID: 19726418.
      View in: PubMed
    248. Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol. 2009 Sep; 8(9):844-56. PMID: 19679276.
      View in: PubMed
    249. Pan T, Rawal P, Wu Y, Xie W, Jankovic J, Le W. Rapamycin protects against rotenone-induced apoptosis through autophagy induction. Neuroscience. 2009 Dec 1; 164(2):541-51. PMID: 19682553.
      View in: PubMed
    250. Jankovic J. Movement disorders. Preface. Neurol Clin. 2009 Aug; 27(3):ix-x. PMID: 19555822.
      View in: PubMed
    251. Jankovic J. Peripherally induced movement disorders. Neurol Clin. 2009 Aug; 27(3):821-32, vii. PMID: 19555833.
      View in: PubMed
    252. Ferrara JM, Kenney C, Davidson AL, Shinawi L, Kissel AM, Jankovic J. Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial. J Neurol Sci. 2009 Oct 15; 285(1-2):195-7. PMID: 19631949.
      View in: PubMed
    253. Ravina B, Elm J, Camicioli R, Como PG, Marsh L, Jankovic J, Weintraub D. The course of depressive symptoms in early Parkinson's disease. Mov Disord. 2009 Jul 15; 24(9):1306-11. PMID: 19412939; PMCID: PMC2788307.
    254. Gupta A, Jankovic J. Spinocerebellar ataxia 8: variable phenotype and unique pathogenesis. Parkinsonism Relat Disord. 2009 Nov; 15(9):621-6. PMID: 19559641.
      View in: PubMed
    255. Sitburana O, Wu LJ, Sheffield JK, Davidson A, Jankovic J. Motor overflow and mirror dystonia. Parkinsonism Relat Disord. 2009 Dec; 15(10):758-61. PMID: 19505838.
      View in: PubMed
    256. Le W, Nguyen D, Lin XW, Rawal P, Huang M, Ding Y, Xie W, Deng H, Jankovic J. Transcription factor PITX3 gene in Parkinson's disease. Neurobiol Aging. 2011 Apr; 32(4):750-3. PMID: 19394114.
      View in: PubMed
    257. Tagliati M, Jankovic J, Pagan F, Susatia F, Isaias IU, Okun MS. Safety of MRI in patients with implanted deep brain stimulation devices. Neuroimage. 2009 Aug; 47 Suppl 2:T53-7. PMID: 19376247.
      View in: PubMed
    258. Jankovic J. Atomoxetine for freezing of gait in Parkinson disease. J Neurol Sci. 2009 Sep 15; 284(1-2):177-8. PMID: 19361809.
      View in: PubMed
    259. Mata IF, Hutter CM, González-Fernández MC, de Pancorbo MM, Lezcano E, Huerta C, Blazquez M, Ribacoba R, Guisasola LM, Salvador C, Gómez-Esteban JC, Zarranz JJ, Infante J, Jankovic J, Deng H, Edwards KL, Alvarez V, Zabetian CP. Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain. Neurogenetics. 2009 Oct; 10(4):347-53. PMID: 19308469; PMCID: PMC2821036.
    260. Guo Y, Jankovic J, Zhu S, Le W, Song Z, Xie W, Liao D, Yang H, Deng H. GIGYF2 Asn56Ser and Asn457Thr mutations in Parkinson disease patients. Neurosci Lett. 2009 May 1; 454(3):209-11. PMID: 19429085.
      View in: PubMed
    261. Wijemanne S, Jankovic J. Hemidystonia-hemiatrophy syndrome. Mov Disord. 2009 Mar 15; 24(4):583-9. PMID: 19097182.
      View in: PubMed
    262. Ferrara J, Jankovic J. Acquired hepatocerebral degeneration. J Neurol. 2009 Mar; 256(3):320-32. PMID: 19224314.
      View in: PubMed
    263. Jankovic J, Kenney C, Grafe S, Goertelmeyer R, Comes G. Relationship between various clinical outcome assessments in patients with blepharospasm. Mov Disord. 2009 Feb 15; 24(3):407-13. PMID: 19053054.
      View in: PubMed
    264. Jankovic J, Albanese A, Hallett M. Unique properties of botulinum toxins. Toxicon. 2009 Oct; 54(5):675. PMID: 19470348.
      View in: PubMed
    265. Ferrara J, Jankovic J. Epidemiology and management of essential tremor in children. Paediatr Drugs. 2009; 11(5):293-307. PMID: 19725596.
      View in: PubMed
    266. Wu LJ, Sitburana O, Davidson A, Jankovic J. Applause sign in Parkinsonian disorders and Huntington's disease. Mov Disord. 2008 Dec 15; 23(16):2307-11. PMID: 18972544.
      View in: PubMed
    267. Jankovic J. Disease-oriented approach to botulinum toxin use. Toxicon. 2009 Oct; 54(5):614-23. PMID: 19073203.
      View in: PubMed
    268. Freeman RD, Zinner SH, Müller-Vahl KR, Fast DK, Burd LJ, Kano Y, Rothenberger A, Roessner V, Kerbeshian J, Stern JS, Jankovic J, Loughin T, Janik P, Shady G, Robertson MM, Lang AE, Budman C, Magor A, Bruun R, Berlin CM. Coprophenomena in Tourette syndrome. Dev Med Child Neurol. 2009 Mar; 51(3):218-27. PMID: 19183216.
      View in: PubMed
    269. Olanow CW, Hauser RA, Jankovic J, Langston W, Lang A, Poewe W, Tolosa E, Stocchi F, Melamed E, Eyal E, Rascol O. A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics. Mov Disord. 2008 Nov 15; 23(15):2194-201. PMID: 18932271.
      View in: PubMed
    270. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008 Nov 15; 23(15):2129-70. PMID: 19025984.
      View in: PubMed
    271. Etiopathogenesis of Parkinson disease: a new beginning? Neuroscientist. 2009 Feb; 15(1):28-35. PMID: 19008336.
      View in: PubMed
    272. Jankovic J, Ashoori A. Movement disorders in musicians. Mov Disord. 2008 Oct 30; 23(14):1957-65. PMID: 18785647.
      View in: PubMed
    273. Deng H, Le WD, Jankovic J. Genetic study of an American family with DYT3 dystonia (lubag). Neurosci Lett. 2008 Dec 26; 448(2):180-3. PMID: 18952144.
      View in: PubMed
    274. Ferrara J, Jankovic J. Psychogenic movement disorders in children. Mov Disord. 2008 Oct 15; 23(13):1875-81. PMID: 18709677.
      View in: PubMed
    275. Hallett M, Evinger C, Jankovic J, Stacy M. Update on blepharospasm: report from the BEBRF International Workshop. Neurology. 2008 Oct 14; 71(16):1275-82. PMID: 18852443; PMCID: PMC2676990.
    276. Atassi MZ, Jankovic J, Dolimbek BZ. Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A. Neurology. 2008 Sep 23; 71(13):1040; author reply 1040-1. PMID: 18809844.
      View in: PubMed
    277. Le W, Pan T, Huang M, Xu P, Xie W, Zhu W, Zhang X, Deng H, Jankovic J. Decreased NURR1 gene expression in patients with Parkinson's disease. J Neurol Sci. 2008 Oct 15; 273(1-2):29-33. PMID: 18684475; PMCID: PMC2572302.
    278. Atassi MZ, Dolimbek BZ, Jankovic J, Steward LE, Aoki KR. Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatment. Mol Immunol. 2008 Sep; 45(15):3878-88. PMID: 18676021.
      View in: PubMed
    279. Stamey W, Davidson A, Jankovic J. Shoulder pain: a presenting symptom of Parkinson disease. J Clin Rheumatol. 2008 Aug; 14(4):253-4. PMID: 18766134.
      View in: PubMed
    280. Jankovic J, Aguilar LG. Current approaches to the treatment of Parkinson's disease. Neuropsychiatr Dis Treat. 2008 Aug; 4(4):743-57. PMID: 19043519; PMCID: PMC2536542.
    281. Brin MF, Comella CL, Jankovic J, Lai F, Naumann M. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay. Mov Disord. 2008 Jul 30; 23(10):1353-60. PMID: 18546321.
      View in: PubMed
    282. Pan T, Kondo S, Zhu W, Xie W, Jankovic J, Le W. Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement. Neurobiol Dis. 2008 Oct; 32(1):16-25. PMID: 18640276.
      View in: PubMed
    283. Strutt AM, Lai EC, Jankovic J, Atassi F, Soety EM, Levin HS, Grossman RG, York MK. Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease. Surg Neurol. 2009 May; 71(5):551-8. PMID: 18514283; PMCID: PMC2735757.
    284. Ashoori A, Jankovic J. Mozart's movements and behaviour: a case of Tourette's syndrome? Postgrad Med J. 2008 Jun; 84(992):313-7. PMID: 18644922.
      View in: PubMed
    285. Pan T, Zhu W, Zhao H, Deng H, Xie W, Jankovic J, Le W. Nurr1 deficiency predisposes to lactacystin-induced dopaminergic neuron injury in vitro and in vivo. Brain Res. 2008 Jul 30; 1222:222-9. PMID: 18579122.
      View in: PubMed
    286. Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Eberly S, Walker F, Factor S, Hunt V, Shinaman A, Jankovic J. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease. Clin Neuropharmacol. 2008 May-Jun; 31(3):127-33. PMID: 18520979.
      View in: PubMed
    287. Molho E, Jankovic J, Lew M. Role of botulinum toxin in the treatment of cervical dystonia. Neurol Clin. 2008 May; 26 Suppl 1:43-53. PMID: 18603167.
      View in: PubMed
    288. Zhu W, Xie W, Pan T, Jankovic J, Li J, Youdim MB, Le W. Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration. J Neurochem. 2008 Jun; 105(5):1970-8. PMID: 18399960.
      View in: PubMed
    289. Zhang J, Sokal I, Peskind ER, Quinn JF, Jankovic J, Kenney C, Chung KA, Millard SP, Nutt JG, Montine TJ. CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol. 2008 Apr; 129(4):526-9. PMID: 18343778; PMCID: PMC2688655.
    290. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008 Apr; 79(4):368-76. PMID: 18344392.
      View in: PubMed
    291. Adam OR, Jankovic J. Symptomatic treatment of Huntington disease. Neurotherapeutics. 2008 Apr; 5(2):181-97. PMID: 18394562.
      View in: PubMed
    292. Kuo SH, Kenney C, Jankovic J. Bilateral pedunculopontine nuclei strokes presenting as freezing of gait. Mov Disord. 2008 Mar 15; 23(4):616-9. PMID: 18181207.
      View in: PubMed
    293. Stamey W, Jankovic J. Impulse control disorders and pathological gambling in patients with Parkinson disease. Neurologist. 2008 Mar; 14(2):89-99. PMID: 18332838.
      View in: PubMed
    294. Jankovic J. Are adenosine antagonists, such as istradefylline, caffeine, and chocolate, useful in the treatment of Parkinson's disease? Ann Neurol. 2008 Mar; 63(3):267-9. PMID: 18383071.
      View in: PubMed
    295. Kenney C, Hunter C, Davidson A, Jankovic J. Metoclopramide, an increasingly recognized cause of tardive dyskinesia. J Clin Pharmacol. 2008 Mar; 48(3):379-84. PMID: 18223146.
      View in: PubMed
    296. Pan S, Rush J, Peskind ER, Galasko D, Chung K, Quinn J, Jankovic J, Leverenz JB, Zabetian C, Pan C, Wang Y, Oh JH, Gao J, Zhang J, Montine T, Zhang J. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform. J Proteome Res. 2008 Feb; 7(2):720-30. PMID: 18186601.
      View in: PubMed
    297. Pan T, Kondo S, Le W, Jankovic J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain. 2008 Aug; 131(Pt 8):1969-78. PMID: 18187492.
      View in: PubMed
    298. Deng H, Le W, Shahed J, Xie W, Jankovic J. Mutation analysis of the parkin and PINK1 genes in American Caucasian early-onset Parkinson disease families. Neurosci Lett. 2008 Jan 3; 430(1):18-22. PMID: 18068301.
      View in: PubMed
    299. Jankovic J. Parkinson's disease and movement disorders: moving forward. Lancet Neurol. 2008 Jan; 7(1):9-11. PMID: 18093549.
      View in: PubMed
    300. Dulay MF, Strutt AM, Levin HS, Jankovic J, Lai EC, Grossman RG, York MK. Depressed mood and memory impairment before and after unilateral posteroventral pallidotomy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2008; 20(3):357-63. PMID: 18806240.
      View in: PubMed
    301. Azher SN, Jankovic J. Clinical aspects of progressive supranuclear palsy. Handb Clin Neurol. 2008; 89:461-73. PMID: 18631769.
      View in: PubMed
    302. May S, Gilman S, Sowell BB, Thomas RG, Stern MB, Colcher A, Tanner CM, Huang N, Novak P, Reich SG, Jankovic J, Ondo WG, Low PA, Sandroni P, Lipp A, Marshall FJ, Wooten F, Shults CW. Potential outcome measures and trial design issues for multiple system atrophy. Mov Disord. 2007 Dec; 22(16):2371-7. PMID: 17914727.
      View in: PubMed
    303. Kuo SH, Jankovic J. Tardive gait. Clin Neurol Neurosurg. 2008 Feb; 110(2):198-201. PMID: 17997030.
      View in: PubMed
    304. Ashoori A, Jankovic J. Mozart's movements and behaviour: a case of Tourette's syndrome? J Neurol Neurosurg Psychiatry. 2007 Nov; 78(11):1171-5. PMID: 17940168; PMCID: PMC2117611.
    305. Diamond A, Kenney C, Almaguer M, Jankovic J. Hyperhidrosis due to deep brain stimulation in a patient with essential tremor. Case report. J Neurosurg. 2007 Nov; 107(5):1036-8. PMID: 17977278.
      View in: PubMed
    306. York MK, Dulay M, Macias A, Levin HS, Grossman R, Simpson R, Jankovic J. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2008 Jul; 79(7):789-95. PMID: 17965146.
      View in: PubMed
    307. Wijemanne S, Jankovic J. Hemiparkinsonism-hemiatrophy syndrome. Neurology. 2007 Oct 16; 69(16):1585-94. PMID: 17938368.
      View in: PubMed
    308. Sitburana O, Jankovic J. Focal hand dystonia, mirror dystonia and motor overflow. J Neurol Sci. 2008 Mar 15; 266(1-2):31-3. PMID: 17888455.
      View in: PubMed
    309. Cheung MY, Shahed J, Jankovic J. Malignant Tourette syndrome. Mov Disord. 2007 Sep 15; 22(12):1743-50. PMID: 17566119.
      View in: PubMed
    310. LeWitt PA, Boroojerdi B, MacMahon D, Patton J, Jankovic J. Overnight switch from oral dopaminergic agonists to transdermal rotigotine patch in subjects with Parkinson disease. Clin Neuropharmacol. 2007 Sep-Oct; 30(5):256-65. PMID: 17909303.
      View in: PubMed
    311. Inzelberg R, Jankovic J. Are Parkinson disease patients protected from some but not all cancers? Neurology. 2007 Oct 9; 69(15):1542-50. PMID: 17699801.
      View in: PubMed
    312. Zhu W, Xie W, Pan T, Xu P, Fridkin M, Zheng H, Jankovic J, Youdim MB, Le W. Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators. FASEB J. 2007 Dec; 21(14):3835-44. PMID: 17690154.
      View in: PubMed
    313. Stamey W, Jankovic J. The other Babinski sign in hemifacial spasm. Neurology. 2007 Jul 24; 69(4):402-4. PMID: 17646635.
      View in: PubMed
    314. Adair JC, Cooke N, Jankovic J. Alexia without agraphia in Creutzfeldt-Jakob disease. J Neurol Sci. 2007 Dec 15; 263(1-2):208-10. PMID: 17628601.
      View in: PubMed
    315. York MK, Lai EC, Jankovic J, Macias A, Atassi F, Levin HS, Grossman RG. Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis. Acta Neurochir (Wien). 2007; 149(9):857-66; discussion 866. PMID: 17624489.
      View in: PubMed
    316. Erer S, Jankovic J. Hereditary chin tremor in Parkinson's disease. Clin Neurol Neurosurg. 2007 Nov; 109(9):784-5. PMID: 17618046.
      View in: PubMed
    317. Jankovic J, Deng H. Candidate locus for chorea and tic disorders at 15q? Pediatr Neurol. 2007 Jul; 37(1):70-3. PMID: 17628228.
      View in: PubMed
    318. Kenney C, Diamond A, Mejia N, Davidson A, Hunter C, Jankovic J. Distinguishing psychogenic and essential tremor. J Neurol Sci. 2007 Dec 15; 263(1-2):94-9. PMID: 17604055.
      View in: PubMed
    319. Ravina B, Camicioli R, Como PG, Marsh L, Jankovic J, Weintraub D, Elm J. The impact of depressive symptoms in early Parkinson disease. Neurology. 2007 Jul 24; 69(4):342-7. PMID: 17581943; PMCID: PMC2031220.
    320. Kenney C, Jankovic J. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neural Transm (Vienna). 2008; 115(4):585-91. PMID: 17558461.
      View in: PubMed
    321. Diamond A, Shahed J, Jankovic J. The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor. J Neurol Sci. 2007 Sep 15; 260(1-2):199-203. PMID: 17561121.
      View in: PubMed
    322. Sheffield JK, Jankovic J. Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease. Expert Rev Neurother. 2007 Jun; 7(6):637-47. PMID: 17563247.
      View in: PubMed
    323. Kenney C, Jankovic J. Rotigotine transdermal patch in the treatment of Parkinson's disease and restless legs syndrome. Expert Opin Pharmacother. 2007 Jun; 8(9):1329-35. PMID: 17563266.
      View in: PubMed
    324. Jankovic J, Watts RL, Martin W, Boroojerdi B. Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson disease. Arch Neurol. 2007 May; 64(5):676-82. PMID: 17502466.
      View in: PubMed
    325. Deng H, Le W, Huang M, Xie W, Pan T, Jankovic J. Genetic analysis of LRRK2 P755L variant in Caucasian patients with Parkinson's disease. Neurosci Lett. 2007 May 29; 419(2):104-7. PMID: 17482357.
      View in: PubMed
    326. Jankovic J, Tsui J, Bergeron C. Prevalence of cervical dystonia and spasmodic torticollis in the United States general population. Parkinsonism Relat Disord. 2007 Oct; 13(7):411-6. PMID: 17442609.
      View in: PubMed
    327. Warren L, Gibson R, Ishihara L, Elango R, Xue Z, Akkari A, Ragone L, Pahwa R, Jankovic J, Nance M, Freeman A, Watts RL, Hentati F. A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease. Parkinsonism Relat Disord. 2008; 14(1):77-80. PMID: 17433753.
      View in: PubMed
    328. Kenney C, Simpson R, Hunter C, Ondo W, Almaguer M, Davidson A, Jankovic J. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg. 2007 Apr; 106(4):621-5. PMID: 17432713.
      View in: PubMed
    329. Ozelius LJ, Foroud T, May S, Senthil G, Sandroni P, Low PA, Reich S, Colcher A, Stern MB, Ondo WG, Jankovic J, Huang N, Tanner CM, Novak P, Gilman S, Marshall FJ, Wooten GF, Chelimsky TC, Shults CW. G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy. Mov Disord. 2007 Mar 15; 22(4):546-9. PMID: 17230458.
      View in: PubMed
    330. Deng H, Le W, Jankovic J. Genetics of essential tremor. Brain. 2007 Jun; 130(Pt 6):1456-64. PMID: 17353225.
      View in: PubMed
    331. Deng H, Le WD, Hunter CB, Mejia N, Xie WJ, Jankovic J. A family with Parkinson disease, essential tremor, bell palsy, and parkin mutations. Arch Neurol. 2007 Mar; 64(3):421-4. PMID: 17353387.
      View in: PubMed
    332. Erer S, Jankovic J. Adult onset tics after peripheral injury. Parkinsonism Relat Disord. 2008; 14(1):75-6. PMID: 17292653.
      View in: PubMed
    333. Kenney C, Hunter C, Jankovic J. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord. 2007 Jan 15; 22(2):193-7. PMID: 17133512.
      View in: PubMed
    334. Shahed J, Poysky J, Kenney C, Simpson R, Jankovic J. GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric comorbidities. Neurology. 2007 Jan 9; 68(2):159-60. PMID: 17210901.
      View in: PubMed
    335. Watts RL, Jankovic J, Waters C, Rajput A, Boroojerdi B, Rao J. Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease. Neurology. 2007 Jan 23; 68(4):272-6. PMID: 17202432.
      View in: PubMed
    336. Kenney C, Hunter C, Davidson A, Jankovic J. Short-term effects of tetrabenazine on chorea associated with Huntington's disease. Mov Disord. 2007 Jan; 22(1):10-3. PMID: 17078062.
      View in: PubMed
    337. Adam OR, Jankovic J. Treatment of dystonia. Parkinsonism Relat Disord. 2007; 13 Suppl 3:S362-8. PMID: 18267265.
      View in: PubMed
    338. Jankovic J, Stacy M. Medical management of levodopa-associated motor complications in patients with Parkinson's disease. CNS Drugs. 2007; 21(8):677-92. PMID: 17630819.
      View in: PubMed
    339. Atassi MZ, Dolimbek BZ, Deitiker P, Jankovic J, Aoki KR. A peptide-based immunoassay for antibodies against botulinum neurotoxin A. J Mol Recognit. 2007 Jan-Feb; 20(1):15-21. PMID: 16981247.
      View in: PubMed
    340. Kenney C, Powell S, Jankovic J. Autopsy-proven Huntington's disease with 29 trinucleotide repeats. Mov Disord. 2007 Jan; 22(1):127-30. PMID: 17115386.
      View in: PubMed
    341. Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord. 2007 Jan; 22(1):41-7. PMID: 17115387.
      View in: PubMed
    342. Ishihara L, Gibson RA, Warren L, Amouri R, Lyons K, Wielinski C, Hunter C, Swartz JE, Elango R, Akkari PA, Leppert D, Surh L, Reeves KH, Thomas S, Ragone L, Hattori N, Pahwa R, Jankovic J, Nance M, Freeman A, Gouider-Khouja N, Kefi M, Zouari M, Ben Sassi S, Ben Yahmed S, El Euch-Fayeche G, Middleton L, Burn DJ, Watts RL, Hentati F. Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families. Mov Disord. 2007 Jan; 22(1):55-61. PMID: 17115391.
      View in: PubMed
    343. Shahed J, Jankovic J. Motor symptoms in Parkinson's disease. Handb Clin Neurol. 2007; 83:329-42. PMID: 18808920.
      View in: PubMed
    344. Jankovic J, Hunter C, Dolimbek BZ, Dolimbek GS, Adler CH, Brashear A, Comella CL, Gordon M, Riley DE, Sethi K, Singer C, Stacy M, Tarsy D, Atassi MZ. Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia. Neurology. 2006 Dec 26; 67(12):2233-5. PMID: 17190952.
      View in: PubMed
    345. Tan EK, Lee J, Hunter C, Shinawi L, Fook-Chong S, Jankovic J. Comparing knowledge and attitudes towards genetic testing in Parkinson's disease in an American and Asian population. J Neurol Sci. 2007 Jan 31; 252(2):113-20. PMID: 17174340.
      View in: PubMed
    346. Deng H, Le WD, Xie WJ, Jankovic J. Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome. Acta Neurol Scand. 2006 Dec; 114(6):400-2. PMID: 17083340.
      View in: PubMed
    347. Deng H, Le W, Guo Y, Hunter CB, Xie W, Huang M, Jankovic J. Genetic analysis of LRRK2 mutations in patients with Parkinson disease. J Neurol Sci. 2006 Dec 21; 251(1-2):102-6. PMID: 17097110.
      View in: PubMed
    348. Wu LJ, Jankovic J. Runner's dystonia. J Neurol Sci. 2006 Dec 21; 251(1-2):73-6. PMID: 17097111.
      View in: PubMed
    349. Mink JW, Walkup J, Frey KA, Como P, Cath D, Delong MR, Erenberg G, Jankovic J, Juncos J, Leckman JF, Swerdlow N, Visser-Vandewalle V, Vitek JL. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord. 2006 Nov; 21(11):1831-8. PMID: 16991144.
      View in: PubMed
    350. Ashour R, Jankovic J. Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Mov Disord. 2006 Nov; 21(11):1856-63. PMID: 16941460.
      View in: PubMed
    351. Jankovic J. Treatment of dystonia. Lancet Neurol. 2006 Oct; 5(10):864-72. PMID: 16987733.
      View in: PubMed
    352. Collins A, Jankovic J. Botulinum toxin injection for congenital muscular torticollis presenting in children and adults. Neurology. 2006 Sep 26; 67(6):1083-5. PMID: 17000985.
      View in: PubMed
    353. Browner N, Azher SN, Jankovic J. Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis. Mov Disord. 2006 Sep; 21(9):1500-2. PMID: 16758485.
      View in: PubMed
    354. Kenney C, Hunter C, Mejia N, Jankovic J. Is history of depression a contraindication to treatment with tetrabenazine? Clin Neuropharmacol. 2006 Sep-Oct; 29(5):259-64. PMID: 16960470.
      View in: PubMed
    355. Tan EK, Jankovic J. Genetic testing in Parkinson disease: promises and pitfalls. Arch Neurol. 2006 Sep; 63(9):1232-7. PMID: 16966499.
      View in: PubMed
    356. Deng H, Le W, Davidson AL, Xie W, Jankovic J. The LRRK2 I2012T, G2019S and I2020T mutations are not common in patients with essential tremor. Neurosci Lett. 2006 Oct 23; 407(2):97-100. PMID: 16939701.
      View in: PubMed
    357. Shahed J, Jankovic J. Exploring the relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord. 2007 Mar; 13(2):67-76. PMID: 16887374.
      View in: PubMed
    358. Abdi F, Quinn JF, Jankovic J, McIntosh M, Leverenz JB, Peskind E, Nixon R, Nutt J, Chung K, Zabetian C, Samii A, Lin M, Hattan S, Pan C, Wang Y, Jin J, Zhu D, Li GJ, Liu Y, Waichunas D, Montine TJ, Zhang J. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimers Dis. 2006 Aug; 9(3):293-348. PMID: 16914840.
      View in: PubMed
    359. Diamond A, Kenney C, Jankovic J. Effect of vagal nerve stimulation in a case of Tourette's syndrome and complex partial epilepsy. Mov Disord. 2006 Aug; 21(8):1273-5. PMID: 16703589.
      View in: PubMed
    360. Ondo WG, Silay Y, Almaguer M, Jankovic J. Subthalamic deep brain stimulation in patients with a previous pallidotomy. Mov Disord. 2006 Aug; 21(8):1252-4. PMID: 16673406.
      View in: PubMed
    361. Diamond A, Jankovic J. Treatment of advanced Parkinson's disease. Expert Rev Neurother. 2006 Aug; 6(8):1181-97. PMID: 16893346.
      View in: PubMed
    362. Jankovic J, Vuong KD, Thomas M. Psychogenic tremor: long-term outcome. CNS Spectr. 2006 Jul; 11(7):501-8. PMID: 16816790.
      View in: PubMed
    363. Jankovic J. An update on the treatment of Parkinson's disease. Mt Sinai J Med. 2006 Jul; 73(4):682-9. PMID: 16878274.
      View in: PubMed
    364. Jeanneteau F, Funalot B, Jankovic J, Deng H, Lagarde JP, Lucotte G, Sokoloff P. A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proc Natl Acad Sci U S A. 2006 Jul 11; 103(28):10753-8. PMID: 16809426; PMCID: PMC1502303.
    365. Thomas M, Vuong KD, Jankovic J. Long-term prognosis of patients with psychogenic movement disorders. Parkinsonism Relat Disord. 2006 Sep; 12(6):382-7. PMID: 16737838.
      View in: PubMed
    366. Diamond A, Jankovic J. Botulinum toxin in dermatology - beyond wrinkles and sweat. J Cosmet Dermatol. 2006 Jun; 5(2):169. PMID: 17173593.
      View in: PubMed
    367. Shatunov A, Sambuughin N, Jankovic J, Elble R, Lee HS, Singleton AB, Dagvadorj A, Ji J, Zhang Y, Kimonis VE, Hardy J, Hallett M, Goldfarb LG. Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23. Brain. 2006 Sep; 129(Pt 9):2318-31. PMID: 16702189.
      View in: PubMed
    368. Dolimbek BZ, Aoki KR, Steward LE, Jankovic J, Atassi MZ. Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A. Mol Immunol. 2007 Feb; 44(5):1029-41. PMID: 16647121.
      View in: PubMed
    369. Deng H, Xie W, Guo Y, Le W, Jankovic J. Gene dosage analysis of alpha-synuclein (SNCA) in patients with Parkinson's disease. Mov Disord. 2006 May; 21(5):728-9. PMID: 16552756.
      View in: PubMed
    370. Diamond A, Shahed J, Azher S, Dat-Vuong K, Jankovic J. Globus pallidus deep brain stimulation in dystonia. Mov Disord. 2006 May; 21(5):692-5. PMID: 16342255.
      View in: PubMed
    371. Jankovic J. Botulinum toxin therapy for cervical dystonia. Neurotox Res. 2006 Apr; 9(2-3):145-8. PMID: 16785112.
      View in: PubMed
    372. Pahwa R, Lyons KE, Wilkinson SB, Simpson RK, Ondo WG, Tarsy D, Norregaard T, Hubble JP, Smith DA, Hauser RA, Jankovic J. Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg. 2006 Apr; 104(4):506-12. PMID: 16619653.
      View in: PubMed
    373. Scahill L, Erenberg G, Berlin CM, Budman C, Coffey BJ, Jankovic J, Kiessling L, King RA, Kurlan R, Lang A, Mink J, Murphy T, Zinner S, Walkup J. Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx. 2006 Apr; 3(2):192-206. PMID: 16554257; PMCID: PMC3593444.
    374. Deng H, Xie WJ, Le WD, Huang MS, Jankovic J. Genetic analysis of the GABRA1 gene in patients with essential tremor. Neurosci Lett. 2006 Jun 19; 401(1-2):16-9. PMID: 16530959.
      View in: PubMed
    375. Pasricha PJ, Pehlivanov N, Sugumar A, Jankovic J. Drug Insight: from disturbed motility to disordered movement--a review of the clinical benefits and medicolegal risks of metoclopramide. Nat Clin Pract Gastroenterol Hepatol. 2006 Mar; 3(3):138-48. PMID: 16511548.
      View in: PubMed
    376. Higgins JJ, Lombardi RQ, Pucilowska J, Jankovic J, Golbe LI, Verhagen L. HS1-BP3 gene variant is common in familial essential tremor. Mov Disord. 2006 Mar; 21(3):306-9. PMID: 16211613.
      View in: PubMed
    377. Deng H, Le WD, Hunter CB, Ondo WG, Guo Y, Xie WJ, Jankovic J. Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations. Arch Neurol. 2006 Feb; 63(2):273-7. PMID: 16476817.
      View in: PubMed
    378. Ondo WG, Jankovic J, Connor GS, Pahwa R, Elble R, Stacy MA, Koller WC, Schwarzman L, Wu SC, Hulihan JF. Topiramate in essential tremor: a double-blind, placebo-controlled trial. Neurology. 2006 Mar 14; 66(5):672-7. PMID: 16436648.
      View in: PubMed
    379. Chu Y, Le W, Kompoliti K, Jankovic J, Mufson EJ, Kordower JH. Nurr1 in Parkinson's disease and related disorders. J Comp Neurol. 2006 Jan 20; 494(3):495-514. PMID: 16320253; PMCID: PMC2564615.
    380. Jankovic J, Kwak C, Frankoff R. Tourette's syndrome and the law. J Neuropsychiatry Clin Neurosci. 2006; 18(1):86-95. PMID: 16525075.
      View in: PubMed
    381. Jankovic J, Mejia NI. Tics associated with other disorders. Adv Neurol. 2006; 99:61-8. PMID: 16536352.
      View in: PubMed
    382. Kenney C, Jankovic J. Tetrabenazine in the treatment of hyperkinetic movement disorders. Expert Rev Neurother. 2006 Jan; 6(1):7-17. PMID: 16466307.
      View in: PubMed
    383. Ondo WG, Fayle R, Atassi F, Jankovic J. Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatry. 2005 Dec; 76(12):1636-9. PMID: 16291885; PMCID: PMC1739456.
    384. Pan T, Li X, Xie W, Jankovic J, Le W. Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cells. FEBS Lett. 2005 Dec 19; 579(30):6716-20. PMID: 16313906.
      View in: PubMed
    385. Jankovic J, Chen S, Le WD. The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease. Prog Neurobiol. 2005 Sep-Oct; 77(1-2):128-38. PMID: 16243425.
      View in: PubMed
    386. Deng H, Jankovic J, Guo Y, Xie W, Le W. Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y. Biochem Biophys Res Commun. 2005 Dec 2; 337(4):1133-8. PMID: 16226715.
      View in: PubMed
    387. Jankovic J. Dystonia and other deformities in Parkinson's disease. J Neurol Sci. 2005 Dec 15; 239(1):1-3. PMID: 16199057.
      View in: PubMed
    388. Tintner R, Gross R, Winzer UF, Smalky KA, Jankovic J. Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial. Neurology. 2005 Sep 13; 65(5):765-7. PMID: 16157918.
      View in: PubMed
    389. Diamond A, Jankovic J. The effect of deep brain stimulation on quality of life in movement disorders. J Neurol Neurosurg Psychiatry. 2005 Sep; 76(9):1188-93. PMID: 16107348; PMCID: PMC1739801.
    390. Imam SZ, Jankovic J, Ali SF, Skinner JT, Xie W, Conneely OM, Le WD. Nitric oxide mediates increased susceptibility to dopaminergic damage in Nurr1 heterozygous mice. FASEB J. 2005 Sep; 19(11):1441-50. PMID: 16126911.
      View in: PubMed
    391. Ross S, Jankovic J. Palatal myoclonus: an unusual presentation. Mov Disord. 2005 Sep; 20(9):1200-3. PMID: 15929094.
      View in: PubMed
    392. Deng H, Le WD, Guo Y, Huang MS, Xie WJ, Jankovic J. Extended study of A265G variant of HS1BP3 in essential tremor and Parkinson disease. Neurology. 2005 Aug 23; 65(4):651-2. PMID: 16116142.
      View in: PubMed
    393. Azher SN, Jankovic J. Camptocormia: pathogenesis, classification, and response to therapy. Neurology. 2005 Aug 9; 65(3):355-9. PMID: 16087897.
      View in: PubMed
    394. Tintner R, Manian P, Gauthier P, Jankovic J. Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease. Arch Neurol. 2005 Aug; 62(8):1290-5. PMID: 16087771.
      View in: PubMed
    395. Truong D, Duane DD, Jankovic J, Singer C, Seeberger LC, Comella CL, Lew MF, Rodnitzky RL, Danisi FO, Sutton JP, Charles PD, Hauser RA, Sheean GL. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord. 2005 Jul; 20(7):783-91. PMID: 15736159.
      View in: PubMed
    396. Ashour R, Tintner R, Jankovic J. Striatal deformities of the hand and foot in Parkinson's disease. Lancet Neurol. 2005 Jul; 4(7):423-31. PMID: 15963445.
      View in: PubMed
    397. Jankovic J. Searching for a relationship between manganese and welding and Parkinson's disease. Neurology. 2005 Jun 28; 64(12):2021-8. PMID: 15985567.
      View in: PubMed
    398. Deng H, Le WD, Zhang X, Pan TH, Jankovic J. G309D and W437OPA PINK1 mutations in Caucasian Parkinson's disease patients. Acta Neurol Scand. 2005 Jun; 111(6):351-2. PMID: 15876334.
      View in: PubMed
    399. Deng H, Le W, Guo Y, Hunter CB, Xie W, Jankovic J. Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation. Ann Neurol. 2005 Jun; 57(6):933-4. PMID: 15929036.
      View in: PubMed
    400. Mejia NI, Vuong KD, Jankovic J. Long-term botulinum toxin efficacy, safety, and immunogenicity. Mov Disord. 2005 May; 20(5):592-7. PMID: 15645481.
      View in: PubMed
    401. Silay YS, Jankovic J. Emerging drugs in Tourette syndrome. Expert Opin Emerg Drugs. 2005 May; 10(2):365-80. PMID: 15934872.
      View in: PubMed
    402. Mejia NI, Jankovic J. Secondary tics and tourettism. Rev Bras Psiquiatr. 2005 Mar; 27(1):11-7. PMID: 15867978.
      View in: PubMed
    403. Deng H, Le WD, Xie WJ, Pan TH, Zhang X, Jankovic J. Genetic analysis of parkin co-regulated gene (PACRG) in patients with early-onset parkinsonism. Neurosci Lett. 2005 Jul 15; 382(3):297-9. PMID: 15925106.
      View in: PubMed
    404. Pan T, Xie W, Jankovic J, Le W. Biological effects of pramipexole on dopaminergic neuron-associated genes: relevance to neuroprotection. Neurosci Lett. 2005 Mar 29; 377(2):106-9. PMID: 15740846.
      View in: PubMed
    405. Wan XH, Vuong KD, Jankovic J. Clinical application of botulinum toxin type B in movement disorders and autonomic symptoms. Chin Med Sci J. 2005 Mar; 20(1):44-7. PMID: 15844312.
      View in: PubMed
    406. Jankovic J. Progression of Parkinson disease: are we making progress in charting the course? Arch Neurol. 2005 Mar; 62(3):351-2. PMID: 15767498.
      View in: PubMed
    407. Jankovic J, Noebels JL. Genetic mouse models of essential tremor: are they essential? J Clin Invest. 2005 Mar; 115(3):584-6. PMID: 15765140; PMCID: PMC1052020.
    408. Olanow CW, Jankovic J. Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy. Mov Disord. 2005; 20 Suppl 11:S3-10. PMID: 15822111.
      View in: PubMed
    409. Jankovic J. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov Disord. 2005; 20 Suppl 11:S11-6. PMID: 15822109.
      View in: PubMed
    410. Jiang C, Wan X, He Y, Pan T, Jankovic J, Le W. Age-dependent dopaminergic dysfunction in Nurr1 knockout mice. Exp Neurol. 2005 Jan; 191(1):154-62. PMID: 15589522.
      View in: PubMed
    411. Mejia NI, Jankovic J. Metoclopramide-induced tardive dyskinesia in an infant. Mov Disord. 2005 Jan; 20(1):86-9. PMID: 15390048.
      View in: PubMed
    412. Jankovic J, Madisetty J, Vuong KD. Essential tremor among children. Pediatrics. 2004 Nov; 114(5):1203-5. PMID: 15520096.
      View in: PubMed
    413. Ondo WG, Jimenez JE, Vuong KD, Jankovic J. An open-label pilot study of levetiracetam for essential tremor. Clin Neuropharmacol. 2004 Nov-Dec; 27(6):274-7. PMID: 15613931.
      View in: PubMed
    414. Jankovic J. Essential tremor course and disability: a clinicopathologic study of 20 cases. Neurology. 2004 Oct 26; 63(8):1541-2; author reply 1541-2. PMID: 15505193.
      View in: PubMed
    415. Deng H, Le W, Jankovic J. Premutation alleles associated with Parkinson disease and essential tremor. JAMA. 2004 Oct 13; 292(14):1685-6. PMID: 15479932.
      View in: PubMed
    416. de Carvalho Aguiar P, Fazzari M, Jankovic J, Ozelius LJ. Examination of the SGCE gene in Tourette syndrome patients with obsessive-compulsive disorder. Mov Disord. 2004 Oct; 19(10):1237-8. PMID: 15368614.
      View in: PubMed
    417. Brodsky H, Dat Vuong K, Thomas M, Jankovic J. Glabellar and palmomental reflexes in Parkinsonian disorders. Neurology. 2004 Sep 28; 63(6):1096-8. PMID: 15452308.
      View in: PubMed
    418. Jankovic J, Esquenazi A, Fehlings D, Freitag F, Lang AM, Naumann M. Evidence-based review of patient-reported outcomes with botulinum toxin type A. Clin Neuropharmacol. 2004 Sep-Oct; 27(5):234-44. PMID: 15602105.
      View in: PubMed
    419. Thomas M, Jankovic J. Neurodegenerative disease and iron storage in the brain. Curr Opin Neurol. 2004 Aug; 17(4):437-42. PMID: 15247539.
      View in: PubMed
    420. Naumann M, Jankovic J. Safety of botulinum toxin type A: a systematic review and meta-analysis. Curr Med Res Opin. 2004 Jul; 20(7):981-90. PMID: 15265242.
      View in: PubMed
    421. Jankovic J. Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatry. 2004 Jul; 75(7):951-7. PMID: 15201348; PMCID: PMC1739107.
    422. Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O'Connell C, Ross T, Richard K, Watts A. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol. 2004 Jul; 61(7):1044-53. PMID: 15262734.
      View in: PubMed
    423. Li YJ, Hauser MA, Scott WK, Martin ER, Booze MW, Qin XJ, Walter JW, Nance MA, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Small GW, Mastaglia F, Haines JL, Pericak-Vance MA, Vance JM. Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology. 2004 Jun 8; 62(11):2005-9. PMID: 15184605.
      View in: PubMed
    424. Thomas M, Ashizawa T, Jankovic J. Minocycline in Huntington's disease: a pilot study. Mov Disord. 2004 Jun; 19(6):692-5. PMID: 15197710.
      View in: PubMed
    425. Suteerawattananon M, Morris GS, Etnyre BR, Jankovic J, Protas EJ. Effects of visual and auditory cues on gait in individuals with Parkinson's disease. J Neurol Sci. 2004 Apr 15; 219(1-2):63-9. PMID: 15050439.
      View in: PubMed
    426. Lassinger BK, Kwak C, Walford RL, Jankovic J. Atypical parkinsonism and motor neuron syndrome in a Biosphere 2 participant: a possible complication of chronic hypoxia and carbon monoxide toxicity? Mov Disord. 2004 Apr; 19(4):465-9. PMID: 15077246.
      View in: PubMed
    427. Jankovic J. Treatment of cervical dystonia with botulinum toxin. Mov Disord. 2004 Mar; 19 Suppl 8:S109-15. PMID: 15027062.
      View in: PubMed
    428. Jiang C, Wan X, Jankovic J, Christian ST, Pristupa ZB, Niznik HB, Sundsmo JS, Le W. Dopaminergic properties and experimental anti-parkinsonian effects of IPX750 in rodent models of Parkinson disease. Clin Neuropharmacol. 2004 Mar-Apr; 27(2):63-73. PMID: 15252266.
      View in: PubMed
    429. Pan T, Le W, Jankovic J. Slowing Parkinson's disease progression: recent dopamine agonist trials. Neurology. 2004 Jan 27; 62(2):343; author reply 343-4. PMID: 14750218.
      View in: PubMed
    430. Thomas M, Jankovic J, Suteerawattananon M, Wankadia S, Caroline KS, Vuong KD, Protas E. Clinical gait and balance scale (GABS): validation and utilization. J Neurol Sci. 2004 Jan 15; 217(1):89-99. PMID: 14675615.
      View in: PubMed
    431. Thomas M, Jankovic J. Psychogenic movement disorders: diagnosis and management. CNS Drugs. 2004; 18(7):437-52. PMID: 15139799.
      View in: PubMed
    432. Thomas M, Hayflick SJ, Jankovic J. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration. Mov Disord. 2004 Jan; 19(1):36-42. PMID: 14743358.
      View in: PubMed
    433. Sanghera MK, Grossman RG, Kalhorn CG, Hamilton WJ, Ondo WG, Jankovic J. Basal ganglia neuronal discharge in primary and secondary dystonia. Adv Neurol. 2004; 94:29-36. PMID: 14509651.
      View in: PubMed
    434. Jankovic J. Dystonia: medical therapy and botulinum toxin. Adv Neurol. 2004; 94:275-86. PMID: 14509685.
      View in: PubMed
    435. Kwak C, Dat Vuong K, Jankovic J. Premonitory sensory phenomenon in Tourette's syndrome. Mov Disord. 2003 Dec; 18(12):1530-3. PMID: 14673893.
      View in: PubMed
    436. Walker RH, Jankovic J, O'Hearn E, Margolis RL. Phenotypic features of Huntington's disease-like 2. Mov Disord. 2003 Dec; 18(12):1527-30. PMID: 14673892.
      View in: PubMed
    437. Tintner R, Jankovic J. Dopamine agonists in Parkinson's disease. Expert Opin Investig Drugs. 2003 Nov; 12(11):1803-20. PMID: 14585056.
      View in: PubMed
    438. Kwak C, Vuong KD, Jankovic J. Migraine headache in patients with Tourette syndrome. Arch Neurol. 2003 Nov; 60(11):1595-8. PMID: 14623732.
      View in: PubMed
    439. Ondo WG, Sutton L, Dat Vuong K, Lai D, Jankovic J. Hearing impairment in essential tremor. Neurology. 2003 Oct 28; 61(8):1093-7. PMID: 14581670.
      View in: PubMed
    440. Li YJ, Oliveira SA, Xu P, Martin ER, Stenger JE, Scherzer CR, Hauser MA, Scott WK, Small GW, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Mastaglia F, Middleton LT, Roses AD, Saunders AM, Schmechel DE, Gullans SR, Haines JL, Gilbert JR, Vance JM, Pericak-Vance MA, Hulette C, Welsh-Bohmer KA. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet. 2003 Dec 15; 12(24):3259-67. PMID: 14570706.
      View in: PubMed
    441. Hill AN, Jankovic J, Vuong KD, Donovan D. Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism. Mov Disord. 2003 Oct; 18(10):1190-2. PMID: 14534926.
      View in: PubMed
    442. He Y, Imam SZ, Dong Z, Jankovic J, Ali SF, Appel SH, Le W. Role of nitric oxide in rotenone-induced nigro-striatal injury. J Neurochem. 2003 Sep; 86(6):1338-45. PMID: 12950443.
      View in: PubMed
    443. Simpkins N, Jankovic J. Neuroprotection in Parkinson disease. Arch Intern Med. 2003 Jul 28; 163(14):1650-4. PMID: 12885679.
      View in: PubMed
    444. Kuniyoshi SM, Jankovic J. MDMA and Parkinsonism. N Engl J Med. 2003 Jul 3; 349(1):96-7. PMID: 12840102.
      View in: PubMed
    445. Oliveira SA, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons KE, Pahwa R, Stern MB, Hiner BC, Jankovic J, Ondo WG, Allen FH, Scott BL, Goetz CG, Small GW, Mastaglia FL, Stajich JM, Zhang F, Booze MW, Reaves JA, Middleton LT, Haines JL, Pericak-Vance MA, Vance JM, Martin ER. Association study of Parkin gene polymorphisms with idiopathic Parkinson disease. Arch Neurol. 2003 Jul; 60(7):975-80. PMID: 12873854.
      View in: PubMed
    446. Sanghera MK, Grossman RG, Kalhorn CG, Hamilton WJ, Ondo WG, Jankovic J. Basal ganglia neuronal discharge in primary and secondary dystonia in patients undergoing pallidotomy. Neurosurgery. 2003 Jun; 52(6):1358-70; discussion 1370-3. PMID: 12762881.
      View in: PubMed
    447. Higgins JJ, Jankovic J, Lombardi RQ, Pucilowska J, Tan EK, Ashizawa T, Ruszczyk MU. Haplotype analysis of the ETM2 locus in familial essential tremor. Neurogenetics. 2003 Aug; 4(4):185-9. PMID: 12761658.
      View in: PubMed
    448. Simon DK, Friedman J, Breakefield XO, Jankovic J, Brin MF, Provias J, Bressman SB, Charness ME, Tarsy D, Johns DR, Tarnopolsky MA. A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia. Neurogenetics. 2003 Aug; 4(4):199-205. PMID: 12756609.
      View in: PubMed
    449. Jankovic J, Vuong KD, Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology. 2003 Apr 8; 60(7):1186-8. PMID: 12682332.
      View in: PubMed
    450. van der Walt JM, Martin ER, Scott WK, Zhang F, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Mastaglia F, Roses AD, Stajich JM, Booze MW, Fujiwara K, Gibson RA, Middleton LT, Scott BL, Pericak-Vance MA, Vance JM. Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease. Neurology. 2003 Apr 8; 60(7):1189-91. PMID: 12682333.
      View in: PubMed
    451. Rosa AL, Jankovic J, Ashizawa T. Screening for mutations in the MECP2 (Rett syndrome) gene in Gilles de la Tourette syndrome. Arch Neurol. 2003 Apr; 60(4):502-3. PMID: 12707062.
      View in: PubMed
    452. Lotze T, Jankovic J. Paroxysmal kinesigenic dyskinesias. Semin Pediatr Neurol. 2003 Mar; 10(1):68-79. PMID: 12785750.
      View in: PubMed
    453. van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Mastaglia F, Stajich JM, McLaurin AC, Middleton LT, Scott BL, Schmechel DE, Pericak-Vance MA, Vance JM. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet. 2003 Apr; 72(4):804-11. PMID: 12618962; PMCID: PMC1180345.
    454. Savant CS, Singhal BS, Jankovic J, Khan M, Virani A. Substantia nigra lesions in viral encephalitis. Mov Disord. 2003 Feb; 18(2):213-6. PMID: 12539218.
      View in: PubMed
    455. Sabbahi M, Etnyre B, Al-Jawayed I, Jankovic J. Soleus H-reflex measures in patients with focal and generalized dystonia. Clin Neurophysiol. 2003 Feb; 114(2):288-94. PMID: 12559236.
      View in: PubMed
    456. Pan T, Fei J, Zhou X, Jankovic J, Le W. Effects of green tea polyphenols on dopamine uptake and on MPP+ -induced dopamine neuron injury. Life Sci. 2003 Jan 17; 72(9):1073-83. PMID: 12495785.
      View in: PubMed
    457. Hou JG, Jankovic J. Movement disorders in Friedreich's ataxia. J Neurol Sci. 2003 Jan 15; 206(1):59-64. PMID: 12480086.
      View in: PubMed
    458. Thomas M, Le WD, Jankovic J. Minocycline and other tetracycline derivatives: a neuroprotective strategy in Parkinson's disease and Huntington's disease. Clin Neuropharmacol. 2003 Jan-Feb; 26(1):18-23. PMID: 12567160.
      View in: PubMed
    459. Lyons KE, Pahwa R, Comella CL, Eisa MS, Elble RJ, Fahn S, Jankovic J, Juncos JL, Koller WC, Ondo WG, Sethi KD, Stern MB, Tanner CM, Tintner R, Watts RL. Benefits and risks of pharmacological treatments for essential tremor. Drug Saf. 2003; 26(7):461-81. PMID: 12735785.
      View in: PubMed
    460. Pan T, Jankovic J, Le W. Potential therapeutic properties of green tea polyphenols in Parkinson's disease. Drugs Aging. 2003; 20(10):711-21. PMID: 12875608.
      View in: PubMed
    461. Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, Vassilatis DK. Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet. 2003 Jan; 33(1):85-9. PMID: 12496759.
      View in: PubMed
    462. Ondo WG, Tintner R, Thomas M, Jankovic J. Tetrabenazine treatment for Huntington's disease-associated chorea. Clin Neuropharmacol. 2002 Nov-Dec; 25(6):300-2. PMID: 12469001.
      View in: PubMed
    463. Ondo WG, Levy JK, Vuong KD, Hunter C, Jankovic J. Olanzapine treatment for dopaminergic-induced hallucinations. Mov Disord. 2002 Sep; 17(5):1031-5. PMID: 12360554.
      View in: PubMed
    464. Dolimbek BZ, Jankovic J, Atassi MZ. Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response. Immunol Invest. 2002 Aug-Nov; 31(3-4):247-62. PMID: 12472183.
      View in: PubMed
    465. Tintner R, Jankovic J. Treatment options for Parkinson's disease. Curr Opin Neurol. 2002 Aug; 15(4):467-76. PMID: 12151845.
      View in: PubMed
    466. Jankovic J. Essential tremor: a heterogenous disorder. Mov Disord. 2002 Jul; 17(4):638-44. PMID: 12210851.
      View in: PubMed
    467. Kwak CH, Jankovic J. Tourettism and dystonia after subcortical stroke. Mov Disord. 2002 Jul; 17(4):821-5. PMID: 12210884.
      View in: PubMed
    468. Blakeley J, Jankovic J. Secondary paroxysmal dyskinesias. Mov Disord. 2002 Jul; 17(4):726-34. PMID: 12210862.
      View in: PubMed
    469. Sabbahi M, Etnyre B, Al-Jawayed I, Jankovic J. H-reflex recovery curves differentiate essential tremor, Parkinson's disease, and the combination of essential tremor and Parkinson's disease. J Clin Neurophysiol. 2002 Jun; 19(3):245-51. PMID: 12226570.
      View in: PubMed
    470. Krauss JK, Jankovic J. Head injury and posttraumatic movement disorders. Neurosurgery. 2002 May; 50(5):927-39; discussion 939-40. PMID: 11950395.
      View in: PubMed
    471. Xu PY, Liang R, Jankovic J, Hunter C, Zeng YX, Ashizawa T, Lai D, Le WD. Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease. Neurology. 2002 Mar 26; 58(6):881-4. PMID: 11914402.
      View in: PubMed
    472. Jankovic J, Hunter C. A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease. Parkinsonism Relat Disord. 2002 Mar; 8(4):271-6. PMID: 12039422.
      View in: PubMed
    473. Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Allen FA, Goetz CG, Mastaglia F, Stajich JM, Gibson RA, Middleton LT, Saunders AM, Scott BL, Small GW, Nicodemus KK, Reed AD, Schmechel DE, Welsh-Bohmer KA, Conneally PM, Roses AD, Gilbert JR, Vance JM, Haines JL, Pericak-Vance MA. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet. 2002 Apr; 70(4):985-93. PMID: 11875758; PMCID: PMC379130.
    474. Ondo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol. 2002 Mar; 59(3):421-4. PMID: 11890847.
      View in: PubMed
    475. Opal P, Tintner R, Jankovic J, Leung J, Breakefield XO, Friedman J, Ozelius L. Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic storm. Mov Disord. 2002 Mar; 17(2):339-45. PMID: 11921121.
      View in: PubMed
    476. Jankovic J. Levodopa strengths and weaknesses. Neurology. 2002 Feb 26; 58(4 Suppl 1):S19-32. PMID: 11909982.
      View in: PubMed
    477. Rye DB, Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology. 2002 Feb 12; 58(3):341-6. PMID: 11839829.
      View in: PubMed
    478. Sethi KD, Jankovic J. Dystonia in spinocerebellar ataxia type 6. Mov Disord. 2002 Jan; 17(1):150-3. PMID: 11835453.
      View in: PubMed
    479. Sabbahi M, Etnyre B, Al-Jawayed IA, Hasson S, Jankovic J. Methods of H-reflex evaluation in the early stages of Parkinson's disease. J Clin Neurophysiol. 2002 Jan; 19(1):67-72. PMID: 11896355.
      View in: PubMed
    480. Jankovic J, Demirkiran M. Classification of paroxysmal dyskinesias and ataxias. Adv Neurol. 2002; 89:387-400. PMID: 11968463.
      View in: PubMed
    481. Blakeley J, Jankovic J. Secondary causes of paroxysmal dyskinesia. Adv Neurol. 2002; 89:401-20. PMID: 11968464.
      View in: PubMed
    482. Tintner R, Jankovic J. Botulinum toxin for the treatment of cervical dystonia. Expert Opin Pharmacother. 2001 Dec; 2(12):1985-94. PMID: 11825330.
      View in: PubMed
    483. Jankovic J. Surgery for Parkinson disease and other movement disorders: benefits and limitations of ablation, stimulation, restoration, and radiation. Arch Neurol. 2001 Dec; 58(12):1970-2. PMID: 11735770.
      View in: PubMed
    484. Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Laing NG, Stajich JM, Ribble RC, Booze MW, Rogala A, Hauser MA, Zhang F, Gibson RA, Middleton LT, Roses AD, Haines JL, Scott BL, Pericak-Vance MA, Vance JM. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA. 2001 Nov 14; 286(18):2245-50. PMID: 11710889; PMCID: PMC3973175.
    485. Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Laing NG, Stajich JM, Slotterbeck B, Booze MW, Ribble RC, Rampersaud E, West SG, Gibson RA, Middleton LT, Roses AD, Haines JL, Scott BL, Vance JM, Pericak-Vance MA. Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA. 2001 Nov 14; 286(18):2239-44. PMID: 11710888.
      View in: PubMed
    486. Ondo W, Dat Vuong K, Almaguer M, Jankovic J, Simpson RK. Thalamic deep brain stimulation: effects on the nontarget limbs. Mov Disord. 2001 Nov; 16(6):1137-42. PMID: 11748749.
      View in: PubMed
    487. Jankovic J. Parkinson's disease. A half century of progress. Neurology. 2001 Nov; 57(10 Suppl 3):S1-3. PMID: 11771154.
      View in: PubMed
    488. Xu P, Liang X, Jankovic J, Le W. Identification of a high frequency of mutation at exon 8 of the ATP7B gene in a Chinese population with Wilson disease by fluorescent PCR. Arch Neurol. 2001 Nov; 58(11):1879-82. PMID: 11708998.
      View in: PubMed
    489. Jankovic J. Needle EMG guidance for injection of botulinum toxin. Needle EMG guidance is rarely required. Muscle Nerve. 2001 Nov; 24(11):1568-70. PMID: 11745964.
      View in: PubMed
    490. Ondo WG, Dat Vuong K, Khan H, Atassi F, Kwak C, Jankovic J. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology. 2001 Oct 23; 57(8):1392-6. PMID: 11673578.
      View in: PubMed
    491. Jankovic J. Tourette's syndrome. N Engl J Med. 2001 Oct 18; 345(16):1184-92. PMID: 11642235.
      View in: PubMed
    492. Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol. 2001 Oct; 58(10):1611-5. PMID: 11594919.
      View in: PubMed
    493. Jankovic J, Tintner R. Dystonia and parkinsonism. Parkinsonism Relat Disord. 2001 Oct; 8(2):109-21. PMID: 11489676.
      View in: PubMed
    494. Tan EK, Jankovic J. Choosing dopamine agonists in Parkinson's disease. Clin Neuropharmacol. 2001 Sep-Oct; 24(5):247-53. PMID: 11586109.
      View in: PubMed
    495. Tintner R, Jankovic J. Focal dystonia: the role of botulinum toxin. Curr Neurol Neurosci Rep. 2001 Jul; 1(4):337-45. PMID: 11898539.
      View in: PubMed
    496. Tan EK, Nagamitsu S, Matsuura T, Khajavi M, Jankovic J, Ondo W, Ashizawa T. Alcohol dehydrogenase polymorphism and Parkinson's disease. Neurosci Lett. 2001 Jun 1; 305(1):70-2. PMID: 11356310.
      View in: PubMed
    497. Weiner WJ, Factor SA, Jankovic J, Hauser RA, Tetrud JW, Waters CH, Shulman LM, Glassman PM, Beck B, Paume D, Doyle C. The long-term safety and efficacy of pramipexole in advanced Parkinson's disease. Parkinsonism Relat Disord. 2001 Apr; 7(2):115-120. PMID: 11248592.
      View in: PubMed
    498. Yoshor D, Hamilton WJ, Ondo W, Jankovic J, Grossman RG. Comparison of thalamotomy and pallidotomy for the treatment of dystonia. Neurosurgery. 2001 Apr; 48(4):818-24; discussion 824-6. PMID: 11322442.
      View in: PubMed
    499. Krauss JK, Simpson RK, Ondo WG, Pohle T, Burgunder JM, Jankovic J. Concepts and methods in chronic thalamic stimulation for treatment of tremor: technique and application. Neurosurgery. 2001 Mar; 48(3):535-41; discussion 541-3. PMID: 11270543.
      View in: PubMed
    500. Jankovic J. Parkinson's disease therapy: treatment of early and late disease. Chin Med J (Engl). 2001 Mar; 114(3):227-34. PMID: 11780303.
      View in: PubMed
    501. Vanek Z, Jankovic J. Dystonia in corticobasal degeneration. Mov Disord. 2001 Mar; 16(2):252-7. PMID: 11295777.
      View in: PubMed
    502. Ondo W, Almaguer M, Jankovic J, Simpson RK. Thalamic deep brain stimulation: comparison between unilateral and bilateral placement. Arch Neurol. 2001 Feb; 58(2):218-22. PMID: 11176959.
      View in: PubMed
    503. Shahed J, Jankovic J. Re-emergence of childhood stuttering in Parkinson's disease: a hypothesis. Mov Disord. 2001 Jan; 16(1):114-8. PMID: 11215569.
      View in: PubMed
    504. Jankovic J. Can peripheral trauma induce dystonia and other movement disorders? Yes! Mov Disord. 2001 Jan; 16(1):7-12. PMID: 11215595.
      View in: PubMed
    505. Hanna PA, Ratkos L, Ondo WG, Jankovic J. Switching from pergolide to pramipexole in patients with Parkinson's disease. J Neural Transm (Vienna). 2001; 108(1):63-70. PMID: 11261747.
      View in: PubMed
    506. Tan EK, Jankovic J. Psychogenic hemifacial spasm. J Neuropsychiatry Clin Neurosci. 2001; 13(3):380-4. PMID: 11514645.
      View in: PubMed
    507. Jankovic J. Differential diagnosis and etiology of tics. Adv Neurol. 2001; 85:15-29. PMID: 11530424.
      View in: PubMed
    508. Le WD, Jankovic J. Are dopamine receptor agonists neuroprotective in Parkinson's disease? Drugs Aging. 2001; 18(6):389-96. PMID: 11419913.
      View in: PubMed
    509. Jankovic J, Lai EC, Ondo WG, Roberts-Warrior D, Olson SL, Krauss JK, Grossman RG. Effects of pallidotomy on gait and balance. Adv Neurol. 2001; 87:271-81. PMID: 11347232.
      View in: PubMed
    510. Lai EC, Jankovic J, Krauss JK, Ondo WG, Grossman RG. Long-term efficacy of posteroventral pallidotomy in the treatment of Parkinson's disease. Neurology. 2000 Oct 24; 55(8):1218-22. PMID: 11071505.
      View in: PubMed
    511. Roberts-Warrior D, Overby A, Jankovic J, Olson S, Lai EC, Krauss JK, Grossman R. Postural control in Parkinson's disease after unilateral posteroventral pallidotomy. Brain. 2000 Oct; 123 ( Pt 10):2141-9. PMID: 11004130.
      View in: PubMed
    512. Ondo W, Warrior D, Overby A, Calmes J, Hendersen N, Olson S, Jankovic J. Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls. Arch Neurol. 2000 Oct; 57(10):1464-9. PMID: 11030799.
      View in: PubMed
    513. Ondo WG, Hunter C, Vuong KD, Jankovic J. The pharmacokinetic and clinical effects of tolcapone on a single dose of sublingual apomorphine in Parkinson's disease. Parkinsonism Relat Disord. 2000 Oct 1; 6(4):237-240. PMID: 10900399.
      View in: PubMed
    514. Rettig GM, York MK, Lai EC, Jankovic J, Krauss JK, Grossman RG, Levin HS. Neuropsychological outcome after unilateral pallidotomy for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2000 Sep; 69(3):326-36. PMID: 10945807; PMCID: PMC1737102.
    515. Jankovic J. Parkinson's disease therapy: tailoring choices for early and late disease, young and old patients. Clin Neuropharmacol. 2000 Sep-Oct; 23(5):252-61. PMID: 11154092.
      View in: PubMed
    516. Tan EK, Khajavi M, Thornby JI, Nagamitsu S, Jankovic J, Ashizawa T. Variability and validity of polymorphism association studies in Parkinson's disease. Neurology. 2000 Aug 22; 55(4):533-8. PMID: 10953187.
      View in: PubMed
    517. Kwak CH, Hanna PA, Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol. 2000 Aug; 57(8):1190-3. PMID: 10927800.
      View in: PubMed
    518. Ondo W, Hunter C, Vuong KD, Schwartz K, Jankovic J. Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. Mov Disord. 2000 Jul; 15(4):678-82. PMID: 10928578.
      View in: PubMed
    519. Tan EK, Matsuura T, Nagamitsu S, Khajavi M, Jankovic J, Ashizawa T. Polymorphism of NACP-Rep1 in Parkinson's disease: an etiologic link with essential tremor? Neurology. 2000 Mar 14; 54(5):1195-8. PMID: 10720300.
      View in: PubMed
    520. Zou L, Xu J, Jankovic J, He Y, Appel SH, Le W. Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice. Neurosci Lett. 2000 Mar 10; 281(2-3):167-70. PMID: 10704769.
      View in: PubMed
    521. Jankovic J, Rajput AH, McDermott MP, Perl DP. The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. Arch Neurol. 2000 Mar; 57(3):369-72. PMID: 10714663.
      View in: PubMed
    522. Ondo WG, Ben-Aire L, Jankovic J, Lai E, Contant C, Grossman R. Weight gain following unilateral pallidotomy in Parkinson's disease. Acta Neurol Scand. 2000 Feb; 101(2):79-84. PMID: 10685852.
      View in: PubMed
    523. Tan EK, Jankovic J. Tardive and idiopathic oromandibular dystonia: a clinical comparison. J Neurol Neurosurg Psychiatry. 2000 Feb; 68(2):186-90. PMID: 10644785; PMCID: PMC1736782.
    524. Tan EK, Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc. 2000 Feb; 131(2):211-6. PMID: 10680389.
      View in: PubMed
    525. Le WD, Jankovic J, Xie W, Appel SH. Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection. J Neural Transm (Vienna). 2000; 107(10):1165-73. PMID: 11129106.
      View in: PubMed
    526. Jankovic J. Essential tremor: clinical characteristics. Neurology. 2000; 54(11 Suppl 4):S21-5. PMID: 10854348.
      View in: PubMed
    527. Tan EK, Jankovic J, Ondo W. Bruxism in Huntington's disease. Mov Disord. 2000 Jan; 15(1):171-3. PMID: 10634263.
      View in: PubMed
    528. Jankovic J. Complications and limitations of drug therapy for Parkinson's disease. Neurology. 2000; 55(12 Suppl 6):S2-6. PMID: 11188970.
      View in: PubMed
    529. Tan EK, Jankovic J. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Neurology. 1999 Dec 10; 53(9):2102-7. PMID: 10599789.
      View in: PubMed
    530. Le W, Conneely OM, He Y, Jankovic J, Appel SH. Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury. J Neurochem. 1999 Nov; 73(5):2218-21. PMID: 10537083.
      View in: PubMed
    531. Jankovic J, Schwartz KS, Ondo W. Re-emergent tremor of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999 Nov; 67(5):646-50. PMID: 10519872; PMCID: PMC1736624.
    532. Le W, Conneely OM, Zou L, He Y, Saucedo-Cardenas O, Jankovic J, Mosier DR, Appel SH. Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice. Exp Neurol. 1999 Oct; 159(2):451-8. PMID: 10506516.
      View in: PubMed
    533. Hanna PA, Janjua FN, Contant CF, Jankovic J. Bilineal transmission in Tourette syndrome. Neurology. 1999 Sep 11; 53(4):813-8. PMID: 10489047.
      View in: PubMed
    534. Scott WK, Yamaoka LH, Stajich JM, Scott BL, Vance JM, Roses AD, Pericak-Vance MA, Watts RL, Nance M, Hubble J, Koller W, Stern MB, Colcher A, Allen FH, Hiner BC, Jankovic J, Ondo W, Laing NG, Mastaglia F, Goetz C, Pappert E, Small GW, Masterman D, Haines JL, Davies TL. The alpha-synuclein gene is not a major risk factor in familial Parkinson disease. Neurogenetics. 1999 Sep; 2(3):191-2. PMID: 10541595.
      View in: PubMed
    535. Jankovic J, Lai E, Ben-Arie L, Krauss JK, Grossman R. Levodopa-induced dyskinesias treated by pallidotomy. J Neurol Sci. 1999 Aug 1; 167(1):62-7. PMID: 10500264.
      View in: PubMed
    536. Ondo WG, Hanna PA, Jankovic J. Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol. Am J Psychiatry. 1999 Aug; 156(8):1279-81. PMID: 10450276.
      View in: PubMed
    537. Jankovic J. New and emerging therapies for Parkinson disease. Arch Neurol. 1999 Jul; 56(7):785-90. PMID: 10404979.
      View in: PubMed
    538. Watts MW, Tan EK, Jankovic J. Bruxism and cranial-cervical dystonia: is there a relationship? Cranio. 1999 Jul; 17(3):196-201. PMID: 10650407.
      View in: PubMed
    539. Ondo W, Hunter C, Almaguer M, Jankovic J. A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease. Mov Disord. 1999 Jul; 14(4):664-8. PMID: 10435505.
      View in: PubMed
    540. Stanley RK, Protas EJ, Jankovic J. Exercise performance in those having Parkinson's disease and healthy normals. Med Sci Sports Exerc. 1999 Jun; 31(6):761-6. PMID: 10378900.
      View in: PubMed
    541. Hanna PA, Jankovic J, Vincent A. Comparison of mouse bioassay and immunoprecipitation assay for botulinum toxin antibodies. J Neurol Neurosurg Psychiatry. 1999 May; 66(5):612-6. PMID: 10209172; PMCID: PMC1736353.
    542. Tan EK, Jankovic J. Bilateral hemifacial spasm: a report of five cases and a literature review. Mov Disord. 1999 Mar; 14(2):345-9. PMID: 10091632.
      View in: PubMed
    543. Le WD, Rowe DB, Jankovic J, Xie W, Appel SH. Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells. Arch Neurol. 1999 Feb; 56(2):194-200. PMID: 10025424.
      View in: PubMed
    544. Hanna PA, Jankovic J, Kirkpatrick JB. Multiple system atrophy: the putative causative role of environmental toxins. Arch Neurol. 1999 Jan; 56(1):90-4. PMID: 9923766.
      View in: PubMed
    545. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol. 1999 Jan; 56(1):98-102. PMID: 9923767.
      View in: PubMed
    546. Zou L, Jankovic J, Rowe DB, Xie W, Appel SH, Le W. Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity. Life Sci. 1999; 64(15):1275-85. PMID: 10227583.
      View in: PubMed
    547. Mathew SJ, Yudofsky SC, McCullough LB, Teasdale TA, Jankovic J. Attitudes toward neurosurgical procedures for Parkinson's disease and obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci. 1999; 11(2):259-67. PMID: 10333998.
      View in: PubMed
    548. Jankovic J, Ben-Arie L, Schwartz K, Chen K, Khan M, Lai EC, Krauss JK, Grossman R. Movement and reaction times and fine coordination tasks following pallidotomy. Mov Disord. 1999 Jan; 14(1):57-62. PMID: 9918345.
      View in: PubMed
    549. Ondo W, Hunter C, Almaguer M, Gancher S, Jankovic J. Efficacy and tolerability of a novel sublingual apomorphine preparation in patients with fluctuating Parkinson's disease. Clin Neuropharmacol. 1999 Jan-Feb; 22(1):1-4. PMID: 10047926.
      View in: PubMed
    550. Wang A, Jankovic J. Hemifacial spasm: clinical findings and treatment. Muscle Nerve. 1998 Dec; 21(12):1740-7. PMID: 9843077.
      View in: PubMed
    551. Wang WW, Khajavi M, Patel BJ, Beach J, Jankovic J, Ashizawa T. The G209A mutation in the alpha-synuclein gene is not detected in familial cases of Parkinson disease in non-Greek and/or Italian populations. Arch Neurol. 1998 Dec; 55(12):1521-3. PMID: 9865795.
      View in: PubMed
    552. Sankhla C, Lai EC, Jankovic J. Peripherally induced oromandibular dystonia. J Neurol Neurosurg Psychiatry. 1998 Nov; 65(5):722-8. PMID: 9810945; PMCID: PMC2170345.
    553. Ondo W, Jankovic J, Schwartz K, Almaguer M, Simpson RK. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor. Neurology. 1998 Oct; 51(4):1063-9. PMID: 9781530.
      View in: PubMed
    554. Litvan I, Jankovic J, Goetz CG, Wenning GK, Sastry N, Jellinger K, McKee A, Lai EC, Brandel JP, Verny M, Ray-Chaudhuri K, Pearce RK, Bartko JJ, Agid Y. Accuracy of the clinical diagnosis of postencephalitic parkinsonism: a clinicopathologic study. Eur J Neurol. 1998 Sep; 5(5):451-457. PMID: 10210873.
      View in: PubMed
    555. Desaloms JM, Krauss JK, Lai EC, Jankovic J, Grossman RG. Posteroventral medial pallidotomy for treatment of Parkinson's disease: preoperative magnetic resonance imaging features and clinical outcome. J Neurosurg. 1998 Aug; 89(2):194-9. PMID: 9688112.
      View in: PubMed
    556. Ondo WG, Desaloms JM, Jankovic J, Grossman RG. Pallidotomy for generalized dystonia. Mov Disord. 1998 Jul; 13(4):693-8. PMID: 9686777.
      View in: PubMed
    557. Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, Bartko JJ, Jankovic J, McKee A, Brandel JP, Chaudhuri KR, Lai EC, D'Olhaberriague L, Pearce RK, Agid Y. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol. 1998 Jul; 55(7):969-78. PMID: 9678315.
      View in: PubMed
    558. Hanna PA, Jankovic J. Mouse bioassay versus Western blot assay for botulinum toxin antibodies: correlation with clinical response. Neurology. 1998 Jun; 50(6):1624-9. PMID: 9633703.
      View in: PubMed
    559. Scarano VR, Jankovic J. Post-traumatic movement disorders: effect of the legal system on outcome. J Forensic Sci. 1998 Mar; 43(2):334-9. PMID: 9544540.
      View in: PubMed
    560. Jankovic J. Medical therapy and botulinum toxin in dystonia. Adv Neurol. 1998; 78:169-83. PMID: 9750914.
      View in: PubMed
    561. Ondo WG, Jankovic J, Lai EC, Sankhla C, Khan M, Ben-Arie L, Schwartz K, Grossman RG, Krauss JK. Assessment of motor function after stereotactic pallidotomy. Neurology. 1998 Jan; 50(1):266-70. PMID: 9443490.
      View in: PubMed
    562. Sankhla C, Jankovic J, Duane D. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections. Mov Disord. 1998 Jan; 13(1):150-4. PMID: 9452341.
      View in: PubMed
    563. Krauss JK, Toups EG, Jankovic J, Grossman RG. Symptomatic and functional outcome of surgical treatment of cervical dystonia. J Neurol Neurosurg Psychiatry. 1997 Nov; 63(5):642-8. PMID: 9408107; PMCID: PMC2169822.
    564. Krauss JK, Desaloms JM, Lai EC, King DE, Jankovic J, Grossman RG. Microelectrode-guided posteroventral pallidotomy for treatment of Parkinson's disease: postoperative magnetic resonance imaging analysis. J Neurosurg. 1997 Sep; 87(3):358-67. PMID: 9285599.
      View in: PubMed
    565. Krauss JK, Jankovic J. Tics secondary to craniocerebral trauma. Mov Disord. 1997 Sep; 12(5):776-82. PMID: 9380066.
      View in: PubMed
    566. Krauss JK, Jankovic J, Lai EC, Rettig GM, Grossman RG. Posteroventral medial pallidotomy in levodopa-unresponsive parkinsonism. Arch Neurol. 1997 Aug; 54(8):1026-9. PMID: 9267978.
      View in: PubMed
    567. Jankovic J, R?zicka E. [Tics and Tourette's syndrome]. Cas Lek Cesk. 1997 Jun 26; 136(13):399-404. PMID: 9333513.
      View in: PubMed
    568. Krauss JK, Jankovic J. Hemidystonia secondary to carotid artery gunshot injury. Childs Nerv Syst. 1997 May; 13(5):285-8. PMID: 9224919.
      View in: PubMed
    569. Jankovic J. Tourette syndrome. Phenomenology and classification of tics. Neurol Clin. 1997 May; 15(2):267-75. PMID: 9115460.
      View in: PubMed
    570. Le W, Jankovic J, Xie W, Kong R, Appel SH. (-)-Deprenyl protection of 1-methyl-4 phenylpyridium ion (MPP+)-induced apoptosis independent of MAO-B inhibition. Neurosci Lett. 1997 Mar 21; 224(3):197-200. PMID: 9131670.
      View in: PubMed
    571. Jankovic J, Beach J, Pandolfo M, Patel PI. Familial essential tremor in 4 kindreds. Prospects for genetic mapping. Arch Neurol. 1997 Mar; 54(3):289-94. PMID: 9074398.
      View in: PubMed
    572. Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology. 1997 Feb; 48(2):358-62. PMID: 9040721.
      View in: PubMed
    573. Krauss JK, Grossman RG, Jankovic J. Improvement of parkinsonian signs after vascular lesions of the basal ganglia circuitry. Mov Disord. 1997 Jan; 12(1):124-6. PMID: 8990069.
      View in: PubMed
    574. Jankovic J, Hamilton WJ, Grossman RG. Thalamic surgery for movement disorders. Adv Neurol. 1997; 74:221-33. PMID: 9348417.
      View in: PubMed
    575. Krauss JK, Grossman RG, Lai EC, Schwartz K, Jankovic J. [Medial posteroventral pallidotomy for the treatment of Parkinson's disease]. Zentralbl Neurochir. 1997; 58(4):153-62. PMID: 9487651.
      View in: PubMed
    576. Jankovic J, Brin MF. Botulinum toxin: historical perspective and potential new indications. Muscle Nerve Suppl. 1997; 6:S129-45. PMID: 9826986.
      View in: PubMed
    577. Alford RL, Ashizawa T, Jankovic J, Caskey CT, Richards CS. Molecular detection of new mutations, resolution of ambiguous results and complex genetic counseling issues in Huntington disease. Am J Med Genet. 1996 Dec 18; 66(3):281-6. PMID: 8985488.
      View in: PubMed
    578. Ondo W, Jankovic J. Restless legs syndrome: clinicoetiologic correlates. Neurology. 1996 Dec; 47(6):1435-41. PMID: 8960723.
      View in: PubMed
    579. Krauss JK, Jankovic J. Surgical treatment of Parkinson's disease. Am Fam Physician. 1996 Oct; 54(5):1621-9. PMID: 8857784.
      View in: PubMed
    580. Krauss JK, Jankovic J. Severe motor tics causing cervical myelopathy in Tourette's syndrome. Mov Disord. 1996 Sep; 11(5):563-6. PMID: 8866498.
      View in: PubMed
    581. Krauss JK, Akeyson EW, Giam P, Jankovic J. Propofol-induced dyskinesias in Parkinson's disease. Anesth Analg. 1996 Aug; 83(2):420-22. PMID: 8694329.
      View in: PubMed
    582. Scott BL, Jankovic J, Donovan DT. Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome. Mov Disord. 1996 Jul; 11(4):431-3. PMID: 8813224.
      View in: PubMed
    583. Ashizawa T, Jankovic J. Cervical dystonia as the initial presentation of Huntington's disease. Mov Disord. 1996 Jul; 11(4):457-9. PMID: 8813235.
      View in: PubMed
    584. Jankovic J, Schwartz K, Clemence W, Aswad A, Mordaunt J. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord. 1996 May; 11(3):250-6. PMID: 8723140.
      View in: PubMed
    585. Demirkiran M, Jankovic J, Dean JM. Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome. Clin Neuropharmacol. 1996 Apr; 19(2):157-64. PMID: 8777769.
      View in: PubMed
    586. Demirkiran M, Jankovic J, Lewis RA, Cox DW. Neurologic presentation of Wilson disease without Kayser-Fleischer rings. Neurology. 1996 Apr; 46(4):1040-3. PMID: 8780087.
      View in: PubMed
    587. Massman PJ, Kreiter KT, Jankovic J, Doody RS. Neuropsychological functioning in cortical-basal ganglionic degeneration: Differentiation from Alzheimer's disease. Neurology. 1996 Mar; 46(3):720-6. PMID: 8618672.
      View in: PubMed
    588. Scott BL, Jankovic J. Delayed-onset progressive movement disorders after static brain lesions. Neurology. 1996 Jan; 46(1):68-74. PMID: 8559423.
      View in: PubMed
    589. Jankovic J, Cardoso F, Grossman RG, Hamilton WJ. Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. Neurosurgery. 1995 Oct; 37(4):680-6; discussion 686-7. PMID: 8559296.
      View in: PubMed
    590. Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol. 1995 Oct; 38(4):571-9. PMID: 7574453.
      View in: PubMed
    591. Jankovic J, Schwartz K. Response and immunoresistance to botulinum toxin injections. Neurology. 1995 Sep; 45(9):1743-6. PMID: 7675238.
      View in: PubMed
    592. Jankovic J. International Classification of Diseases, tenth revision: neurological adaptation (ICD-10 NA): extrapyramidal and movement disorders. Mov Disord. 1995 Sep; 10(5):533-40. PMID: 8552102.
      View in: PubMed
    593. Jankovic J, Beach J, Ashizawa T. Emotional and functional impact of DNA testing on patients with symptoms of Huntington's disease. J Med Genet. 1995 Jul; 32(7):516-8. PMID: 7562962; PMCID: PMC1050542.
    594. Jankovic J. Tardive syndromes and other drug-induced movement disorders. Clin Neuropharmacol. 1995 Jun; 18(3):197-214. PMID: 8635179.
      View in: PubMed
    595. Jankovic J, Beach J, Schwartz K, Contant C. Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects. Neurology. 1995 Apr; 45(4):645-8. PMID: 7723949.
      View in: PubMed
    596. Cardoso F, Jankovic J. Peripherally induced tremor and parkinsonism. Arch Neurol. 1995 Mar; 52(3):263-70. PMID: 7872879.
      View in: PubMed
    597. Cardoso F, Jankovic J, Grossman RG, Hamilton WJ. Outcome after stereotactic thalamotomy for dystonia and hemiballismus. Neurosurgery. 1995 Mar; 36(3):501-7; discussion 507-8. PMID: 7753350.
      View in: PubMed
    598. Chacko RC, Hurley RA, Harper RG, Jankovic J, Cardoso F. Clozapine for acute and maintenance treatment of psychosis in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1995; 7(4):471-5. PMID: 8555750.
      View in: PubMed
    599. Jankovic J, Ashizawa T. Tourettism associated with Huntington's disease. Mov Disord. 1995 Jan; 10(1):103-5. PMID: 7885343.
      View in: PubMed
    600. Jankovic J. Post-traumatic movement disorders: central and peripheral mechanisms. Neurology. 1994 Nov; 44(11):2006-14. PMID: 7969951.
      View in: PubMed
    601. Jankovic J. Botulinum toxin in movement disorders. Curr Opin Neurol. 1994 Aug; 7(4):358-66. PMID: 7952246.
      View in: PubMed
    602. Ashizawa T, Wong LJ, Richards CS, Caskey CT, Jankovic J. CAG repeat size and clinical presentation in Huntington's disease. Neurology. 1994 Jun; 44(6):1137-43. PMID: 8208412.
      View in: PubMed
    603. Jankovic J. Botulinum toxin in the treatment of dystonic tics. Mov Disord. 1994 May; 9(3):347-9. PMID: 8041378.
      View in: PubMed
    604. Piwinski SE, Jankovic J, McElligott MA. A comparison of postspace-flight orthostatic intolerance to vasovagal syncope and autonomic failure and the potential use of the alpha agonist midodrine for these conditions. J Clin Pharmacol. 1994 May; 34(5):466-71. PMID: 7522240.
      View in: PubMed
    605. Percy AK, Glaze DG, Schultz RJ, Zoghbi HY, Williamson D, Frost JD, Jankovic JJ, del Junco D, Skender M, Waring S, et al. Rett syndrome: controlled study of an oral opiate antagonist, naltrexone. Ann Neurol. 1994 Apr; 35(4):464-70. PMID: 8154874.
      View in: PubMed
    606. Winikates J, Jankovic J. Vascular progressive supranuclear palsy. J Neural Transm Suppl. 1994; 42:189-201. PMID: 7964687.
      View in: PubMed
    607. Jankovic J, Rajput AH, Golbe LI, Goodman JC. What is it? Case 1, 1993: parkinsonism, dysautonomia, and ophthalmoparesis. Mov Disord. 1993 Oct; 8(4):525-32. PMID: 8232366.
      View in: PubMed
    608. Jankovic J, Schwartz KS. Use of botulinum toxin in the treatment of hand dystonia. J Hand Surg Am. 1993 Sep; 18(5):883-7. PMID: 8228064.
      View in: PubMed
    609. Cardoso FE, Jankovic J. Hereditary motor-sensory neuropathy and movement disorders. Muscle Nerve. 1993 Sep; 16(9):904-10. PMID: 8355721.
      View in: PubMed
    610. Jankovic J, Gilden JL, Hiner BC, Kaufmann H, Brown DC, Coghlan CH, Rubin M, Fouad-Tarazi FM. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med. 1993 Jul; 95(1):38-48. PMID: 7687093.
      View in: PubMed
    611. Stacy M, Cardoso F, Jankovic J. Tardive stereotypy and other movement disorders in tardive dyskinesias. Neurology. 1993 May; 43(5):937-41. PMID: 8492949.
      View in: PubMed
    612. Cardoso FE, Jankovic J. Cocaine-related movement disorders. Mov Disord. 1993 Apr; 8(2):175-8. PMID: 8474485.
      View in: PubMed
    613. Jankovic J, Schwartz KS. Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology. 1993 Apr; 43(4):834-6. PMID: 8469349.
      View in: PubMed
    614. Jankovic J. Deprenyl in attention deficit associated with Tourette's syndrome. Arch Neurol. 1993 Mar; 50(3):286-8. PMID: 8442708.
      View in: PubMed
    615. Monday K, Jankovic J. Psychogenic myoclonus. Neurology. 1993 Feb; 43(2):349-52. PMID: 8437701.
      View in: PubMed
    616. Doody RS, Jankovic J. The alien hand and related signs. J Neurol Neurosurg Psychiatry. 1992 Sep; 55(9):806-10. PMID: 1402972; PMCID: PMC1015106.
    617. Burnett L, Jankovic J. Chorea and ballism. Curr Opin Neurol Neurosurg. 1992 Jun; 5(3):308-13. PMID: 1535815.
      View in: PubMed
    618. Jankovic J, Wooten M, Van der Linden C, Jansson B. Low body weight in Parkinson's disease. South Med J. 1992 Apr; 85(4):351-4. PMID: 1566133.
      View in: PubMed
    619. Lew H, Jordan C, Jerger J, Jankovic J. Acoustic reflex abnormalities in cranial-cervical dystonia. Neurology. 1992 Mar; 42(3 Pt 1):594-7. PMID: 1549220.
      View in: PubMed
    620. Stacy M, Jankovic J. Tardive tremor. Mov Disord. 1992; 7(1):53-7. PMID: 1348352.
      View in: PubMed
    621. Miller LG, Jankovic J. Persistent dystonia possibly induced by flecainide. Mov Disord. 1992; 7(1):62-3. PMID: 1557067.
      View in: PubMed
    622. Jankovic J. Diagnosis and classification of tics and Tourette syndrome. Adv Neurol. 1992; 58:7-14. PMID: 1414646.
      View in: PubMed
    623. Jankovic J, Schwartz KS. Clinical correlates of response to botulinum toxin injections. Arch Neurol. 1991 Dec; 48(12):1253-6. PMID: 1845028.
      View in: PubMed
    624. Taylor LD, Krizman DB, Jankovic J, Hayani A, Steuber PC, Greenberg F, Fenwick RG, Caskey CT. 9p monosomy in a patient with Gilles de la Tourette's syndrome. Neurology. 1991 Sep; 41(9):1513-5. PMID: 1679912.
      View in: PubMed
    625. Stone LA, Jankovic J. The coexistence of tics and dystonia. Arch Neurol. 1991 Aug; 48(8):862-5. PMID: 1898264.
      View in: PubMed
    626. Jankovic J, Leder S, Warner D, Schwartz K. Cervical dystonia: clinical findings and associated movement disorders. Neurology. 1991 Jul; 41(7):1088-91. PMID: 2067638.
      View in: PubMed
    627. Narayan RK, Loubser PG, Jankovic J, Donovan WH, Bontke CF. Intrathecal baclofen for intractable axial dystonia. Neurology. 1991 Jul; 41(7):1141-2. PMID: 2067645.
      View in: PubMed
    628. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med. 1991 Apr 25; 324(17):1186-94. PMID: 2011163.
      View in: PubMed
    629. Lou JS, Jankovic J. Essential tremor: clinical correlates in 350 patients. Neurology. 1991 Feb; 41(2 ( Pt 1)):234-8. PMID: 1992367.
      View in: PubMed
    630. Blum P, Jankovic J. Stiff-person syndrome: an autoimmune disease. Mov Disord. 1991; 6(1):12-20. PMID: 2005917.
      View in: PubMed
    631. FitzGerald PM, Jankovic J. Orthostatic tremor: an association with essential tremor. Mov Disord. 1991; 6(1):60-4. PMID: 2005923.
      View in: PubMed
    632. Jankovic J, Stone L. Dystonic tics in patients with Tourette's syndrome. Mov Disord. 1991; 6(3):248-52. PMID: 1922130.
      View in: PubMed
    633. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology. 1990 Oct; 40(10):1529-34. PMID: 2215943.
      View in: PubMed
    634. Persing JA, Muir A, Becker DG, Jankovic JJ, Anderson RL, Edlich RF. Blepharospasm-oromandibular dystonia associated with a left cerebellopontine angle meningioma. J Emerg Med. 1990 Sep-Oct; 8(5):571-4. PMID: 2254604.
      View in: PubMed
    635. Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry. 1990 Aug; 53(8):633-9. PMID: 2213039; PMCID: PMC488162.
    636. Miller LG, Jankovic J. Neurologic approach to drug-induced movement disorders: a study of 125 patients. South Med J. 1990 May; 83(5):525-32. PMID: 1971459.
      View in: PubMed
    637. FitzGerald PM, Jankovic J, Glaze DG, Schultz R, Percy AK. Extrapyramidal involvement in Rett's syndrome. Neurology. 1990 Feb; 40(2):293-5. PMID: 2073236.
      View in: PubMed
    638. Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology. 1990 Feb; 40(2):277-80. PMID: 2300249.
      View in: PubMed
    639. Miller LG, Jankovic J. Sulpiride-induced tardive dystonia. Mov Disord. 1990; 5(1):83-4. PMID: 1967484.
      View in: PubMed
    640. Jankovic J, Friedman DI, Pirozzolo FJ, McCrary JA. Progressive supranuclear palsy: motor, neurobehavioral, and neuro-ophthalmic findings. Adv Neurol. 1990; 53:293-304. PMID: 2239467.
      View in: PubMed
    641. FitzGerald PM, Jankovic J, Percy AK. Rett syndrome and associated movement disorders. Mov Disord. 1990; 5(3):195-202. PMID: 2388636.
      View in: PubMed
    642. Miller LG, Jankovic J. Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. Arch Intern Med. 1989 Nov; 149(11):2486-92. PMID: 2684075.
      View in: PubMed
    643. FitzGerald PM, Jankovic J. Tardive oculogyric crises. Neurology. 1989 Nov; 39(11):1434-7. PMID: 2573005.
      View in: PubMed
    644. Jankovic J, Grossman R, Goodman C, Pirozzolo F, Schneider L, Zhu Z, Scardino P, Garber AJ, Jhingran SG, Martin S. Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease. Neurology. 1989 Sep; 39(9):1227-34. PMID: 2475820.
      View in: PubMed
    645. Dewey RB, Jankovic J. Hemiballism-hemichorea. Clinical and pharmacologic findings in 21 patients. Arch Neurol. 1989 Aug; 46(8):862-7. PMID: 2757526.
      View in: PubMed
    646. Jankovic J, Shale H. Dystonia in musicians. Semin Neurol. 1989 Jun; 9(2):131-5. PMID: 2602695.
      View in: PubMed
    647. Jankovic J. Parkinsonism-plus syndromes. Mov Disord. 1989; 4 Suppl 1:S95-119. PMID: 2657411.
      View in: PubMed
    648. Jankovic J, Schwartz K, Vander Linden C. Comparison of Sinemet CR4 and standard Sinemet: double blind and long-term open trial in parkinsonian patients with fluctuations. Mov Disord. 1989; 4(4):303-9. PMID: 2682215.
      View in: PubMed
    649. FitzGerald PM, Jankovic J. Lower body parkinsonism: evidence for vascular etiology. Mov Disord. 1989; 4(3):249-60. PMID: 2779595.
      View in: PubMed
    650. Jankovic J, Van der Linden C. Dystonia and tremor induced by peripheral trauma: predisposing factors. J Neurol Neurosurg Psychiatry. 1988 Dec; 51(12):1512-9. PMID: 3221219; PMCID: PMC1032766.
    651. Jankovic J. Parkinson's disease: recent advances in therapy. South Med J. 1988 Aug; 81(8):1021-7. PMID: 3043683.
      View in: PubMed
    652. Jankovic J, Caskey TC, Stout JT, Butler IJ. Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters. Ann Neurol. 1988 May; 23(5):466-9. PMID: 2455472.
      View in: PubMed
    653. Rosenbaum F, Jankovic J. Focal task-specific tremor and dystonia: categorization of occupational movement disorders. Neurology. 1988 Apr; 38(4):522-7. PMID: 3352903.
      View in: PubMed
    654. Jankovic J, Orman J. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology. 1988 Mar; 38(3):391-4. PMID: 3279337.
      View in: PubMed
    655. Jankovic J, Nutt JG. Blepharospasm and cranial-cervical dystonia (Meige's syndrome): familial occurrence. Adv Neurol. 1988; 49:117-23. PMID: 3344632.
      View in: PubMed
    656. Jankovic J, Armstrong D, Low NL, Rapin I. Case 3, 1988. Progressive myoclonic epilepsy, dementia, and blindness in a young girl. Mov Disord. 1988; 3(4):362-9. PMID: 3145418.
      View in: PubMed
    657. Jankovic J. Cranial-cervical dyskinesias: an overview. Adv Neurol. 1988; 49:1-13. PMID: 3278534.
      View in: PubMed
    658. Jankovic J. Etiology and differential diagnosis of blepharospasm and oromandibular dystonia. Adv Neurol. 1988; 49:103-16. PMID: 3278535.
      View in: PubMed
    659. Jankovic J. Orofacial and other self-mutilations. Adv Neurol. 1988; 49:365-81. PMID: 3278547.
      View in: PubMed
    660. Jankovic J. Botulinum A toxin in the treatment of blepharospasm. Adv Neurol. 1988; 49:467-72. PMID: 3278552.
      View in: PubMed
    661. Jankovic J. Blepharospasm and oromandibular-laryngeal-cervical dystonia: a controlled trial of botulinum A toxin therapy. Adv Neurol. 1988; 50:583-91. PMID: 3041763.
      View in: PubMed
    662. Percy AK, Zoghbi HY, Lewis KR, Jankovic J. Rett syndrome: qualitative and quantitative differentiation from autism. J Child Neurol. 1988; 3 Suppl:S65-7. PMID: 3198904.
      View in: PubMed
    663. Jankovic J, Armstrong D, Low NL, Goetz CG. Case 2, 1988. Congenital mental retardation and juvenile parkinsonism. Mov Disord. 1988; 3(4):352-61. PMID: 3211183.
      View in: PubMed
    664. Singh SK, Jankovic J. Tardive dystonia in patients with Tourette's syndrome. Mov Disord. 1988; 3(3):274-80. PMID: 2904122.
      View in: PubMed
    665. Jankovic J, Casabona J. Coexistent tardive dyskinesia and parkinsonism. Clin Neuropharmacol. 1987 Dec; 10(6):511-21. PMID: 2892586.
      View in: PubMed
    666. Jankovic J, Rohaidy H. Motor, behavioral and pharmacologic findings in Tourette's syndrome. Can J Neurol Sci. 1987 Aug; 14(3 Suppl):541-6. PMID: 2890426.
      View in: PubMed
    667. Little JT, Jankovic J. Tardive myoclonus. Mov Disord. 1987; 2(4):307-11. PMID: 3504556.
      View in: PubMed
    668. Jankovic J, Patten BM. Blepharospasm and autoimmune diseases. Mov Disord. 1987; 2(3):159-63. PMID: 3509774.
      View in: PubMed
    669. Gospe SM, Jankovic J. Drug-induced dystonia in neuronal ceroid-lipofuscinosis. Pediatr Neurol. 1986 Jul-Aug; 2(4):236-7. PMID: 3508694.
      View in: PubMed
    670. Jankovic J, Fahn S. The phenomenology of tics. Mov Disord. 1986; 1(1):17-26. PMID: 3332803.
      View in: PubMed
    671. Jankovic J, Newmark M, Peter P. Parkinsonism and acquired hydrocephalus. Mov Disord. 1986; 1(1):59-64. PMID: 3504232.
      View in: PubMed
    JANKOVIC's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _